ELUCIDATING THE ROLE OF AUTOPHAGY IN ZEBRAFISH MODELS OF LIVER CANCER. by SIM HUEY FEN, TINA
  
ELUCIDATING THE ROLE OF AUTOPHAGY IN 


































ELUCIDATING THE ROLE OF AUTOPHAGY IN 


















A THESIS SUBMITTED  
 
FOR THE DEGREE OF MASTER OF SCIENCE 
 
DEPARTMENT OF BIOLOGICAL SCIENCES  
 














 I would like to take this opportunity to express my greatest gratitude to my 
honorific supervisors, Professor Gong Zhiyuan (Department of Biological Sciences, 
Faculty of Science, NUS), and Associate Professor Shen Han Ming (Department 
of Epidemiology and Public Health, Yong Loo Lin School of Medicine, NUS) for 
taking me under their wing, as well as for their patience, and invaluable advice and 
encouragement offered throughout the entirety of my research. I would also like to 
express my gratitude to fellow laboratory mates from Prof Gong’s laboratory, both 
past and present, namely, Weiling, Grace, Li Zhen, Zhou Li, Cai Xia, Anh Tuan, 
Lili, Sahar, Xiao Qian, Hongyan, Xiaoyan, Shen Yuan, Ti Weng, Yin Ao, 
Myintzu, Yan Tie, Huiqing and Zhengyuan for their advice and encouragement. 
Special thanks to Jianzhou for the engaging brainstorming sessions and assistance 
rendered during my research; and Lora for making my stay in the lab a very 
memorable one. I also appreciate the favours from the members of A/P Shen’s 
laboratory, especially Zhou Jing, even though I am not a full member of the 
laboratory. I would also like to take this opportunity to thank staff from the fish 
facility in the department for their efforts in maintaining quality fish stocks as well as 
general assistance rendered. In addition, I would like to take this opportunity to show 
my appreciation to the National University of Singapore for providing me with the 
graduate research scholarship during these few years. 
Last but not least, I would like to express my love and gratitude to my dearest 
family for their love and unwavering support while I pursue my dreams and passion in 
research. 
 




Table of contents 
Acknowledgements i 
Table of Contents ii-iv  
Summary v-vi 
List of Tables vii 
List of Figures viii-x 
List of Common Abbreviations  xi-xii 
 
Introduction 1 
1. The use of zebrafish as a model organism for the study of cancer 2 
1.1 The use of zebrafish as a model organism in vertebrate developmental 
biology studies 
2 
1.2 The use of zebrafish as a model organism  in cancer studies 4 
1.3 Generation of inducible Xmrk and cmyc driven liver cancer models 7 
1.3.1 The use of inducible promoter systems to control transgene 
expression  
7 
1.3.2 The use of transposable elements to generate transgenic 
zebrafish  
8 
1.3.3 Xmrk and cmyc driven liver cancer models 9 
2. An introduction to autophagy and its involvement in cancer 11 
2.1 Autophagy as a basal and inducible cellular process 11 
2.2 Molecular machinery of autophagy 13 
2.3 Regulation of autophagy 18 
2.4 The use of EGFP-LC3 and mRFP-EGFP-LC3 to study autophagy in 
vivo 
23 
2.5 Autophagy in cancer 25 
3. Rationale of current study 29 
3.1 Establishing Tg(fabp10:egfp-lc3) and Tg(fabp10:mrfp-egfp-lc3)  
transgenic zebrafish for studying autophagy  
29 
3.2 Establishing the role of autophagy in liver cancer 30 
3.3 Objectives of study 31 
  
Materials and Methods 33 
1. Zebrafish care and maintenance and tissue collection  34 
1.1 Zebrafish maintenance 34 
1.2 Zebrafish spawning and embryo collection 34 
1.3 Microinjection into one-cell stage embryos 35 




1.4 Larval screening and photo-documentation 36 
1.5 Liver tissue collection from adult zebrafish 36 
2. RNA applications 37 
2.1 Total RNA isolation from embryos and larvae 37 
2.2 RNA quantification 38 
2.3 Ac mRNA preparation 38 
3. DNA applications 39 
3.1 Total DNA isolation 39 
3.2 cDNA synthesis 40 
3.3 Construction of plasmid DNA 41 
3.3.1 Restriction endonuclease digestion of DNA 41 
3.3.2 Recovery of DNA fragments from DNA gel 43 
3.3.3 Ligation  43 
3.3.4 Competent cell preparation  44 
3.3.5 Transformation and re-transformation reactions 45 
3.3.6 Colony screening 46 
3.3.7 Bacterial cell culture and plasmid amplification 46 
3.3.8 Plasmid isolation and purification 46 
3.4 Polymerase chain reaction 47 
3.4.1 Standard PCR 48 
3.4.2 2-step reverse transcription polymerase chain reaction (2-step 
RT-PCR) 
50 
3.5 DNA vectors 52 
3.5.1 pLF3.0-EGFP 52 
3.5.2 pEGFP-LC3 53 
3.5.3 pmRFP-EGFP-LC3 54 
3.5.4 pMDS6 55 
3.5.5 pAc-SP6 56 
4. Protein applications 57 
4.1 Total protein isolation and extraction 57 
4.2 Protein quantification 57 
4.3 Protein detection  58 
4.3.1 SDS-PAGE gel casting 58 
4.3.2 Running SDS-PAGE 59 
4.3.3 Protein transfer from PAGE gel to Polyvinylidene fluoride 
(PVDF) membrane 
60 
4.3.4 Immunoblotting 60 
4.3.5 Protein band detection 61 
4.3.6 Calculating band intensity from immunoblots 61 
5. Starvation and chemical treatments 62 
5.1 Starvation treatments 62 
5.2 Chemical treatments 63 
5.3 Doxycycline induction of Xmrk and cmyc transgene expression 64 




6. External photo-documentation of adult treated transgenic fish 64 
7. Cryosectioning 65 
7.1Cryostat sections of larvae 65 
7.2 Cryostat sections of adult tissues 66 
7.3 Hoechst staining 66 
8. Confocal imaging 66 
8.1 Live confocal imaging 66 
8.2 Confocal imaging of sections 67 
9. Bioinformatics and sequence analyses 67 
10. Analyses of liver transcriptome data by deep sequencing 68 
  
Results 69 
1. Conserved autophagic machinery in zebrafish 70 
1.1 Atg gene expression in zebrafish 70 
1.2 Conservation of Atg proteins in zebrafish 76 
1.3 Expression of autophagic genes and proteins in zebrafish 77 
1.4 Conserved autophagic machinery in zebrafish 81 
2. Establishment and characterisation of Tg(fabp10:egfp-lc3) 
transgenic line 
85 
2.1 Establishing Tg(fabp10:egfp-lc3) transgenic line 85 
2.2 Characterisation of Tg(fabp10:egfp-lc3) transgenic line 93 
3. Establishment and characterisation of Tg(fabp10:mrfp-egfp-lc3) 
transgenic line 
99 
3.1 Establishing Tg(fabp10:mrfp-egfp-lc3) transgenic line 99 
3.2 Characterisation of Tg(fabp10:mrfp-egfp-lc3) transgenic line 104 
4. Establishing the role of autophagy in liver cancer 108 
4.1 Preliminary data implicating autophagy inhibition in liver cancer  110 
4.2 Establishing double transgenic lines with liver-specific oncogene over-
expression and EGFP-LC3 expression to study the role of autophagy in 
liver cancer 
112 
4.2.1 Tg(fabp10:TA; TRE:Xmrk; krt4:GFP) 115 
4.2.2 Tg(fabp10:TA; TRE:cmyc; krt4:RFP) 116 
  
Discussion 124 
1. Conserved autophagic machinery in zebrafish  125 
2. Establishment and characterisation of Tg(fabp10:egfp-lc3) 
transgenic line 
130 
3. Establishment and characterisation of Tg(fabp10:mrfp-egfp-lc3) 
transgenic line 
134 
4. Establishing the role of autophagy in liver cancer 135 








Autophagy is an evolutionarily conserved cellular process that involves 
autophagosomal sequestration of cytoplasm, long-lived proteins and organelles, and 
subsequent lysosomal degradation, in response to cellular stress such as starvation. It 
is also involved in the degradation of superfluous organelles, proteins and protein 
aggregates. In addition to its main role in regulating basal cellular homeostasis, it has 
also been implicated in a number of diseases. Presently, there are evidences 
implicating autophagy induction and inhibition during carcinogenesis; however the 
exact role of autophagy in carcinogenesis remains to be elucidated. With the zebrafish 
gaining popularity as a model organism in the study of human diseases including 
cancers, we aim to investigate the role of autophagy in liver cancer using our 
established zebrafish liver cancer models. As little study is so far conducted on 
autophagy in zebrafish, we first characterized autophagy in zebrafish, and found the 
autophagic machinery and function are well-conserved between human and zebrafish. 
We also established and characterized a transgenic line, Tg(fabp10:egfp-lc3), with 
constitutively liver-specific egfp-lc3 expression, in order to visualize the autophagic 
flux in the liver. We found that this transgenic line is able to produce EGFP-LC3 
puncta under starvation and everolimus treatment, both processes inducing autophagy. 
Preliminary studies using our liver cancer transgenic zebrafish with inducible 
expression of cmyc or Xmrk oncogene in the liver suggested that autophagy may be 
inhibited during liver carcinogenesis. To further study this phenomenon, we crossed 
Tg(fabp10:egfp-lc3) with these oncogene transgenic lines in order to visualize the 
autophagic flux during tumour initiation, progression and regression in vivo, and we 
obtained evidences suggesting autophagy inhibition during liver carcinogenesis. We 





regression, although more studies need to be performed to validate our observations. 
Finally, we also developed a transgenic line with constitutively liver-specific mrfp-
egfp-lc3 expression. This transgenic line was developed based on the concept of 
lysosomal quenching of GFP fluorescence, with the mRFP-EGFP-LC3 reporter 
labelling autophagosomes yellow and autolysosomes red, thus allowing autophagic 
flux to be measured by comparing the ratio between yellow and red puncta. This will 
be the first attempt in generating a transgenic organism expressing this novel reporter. 
We hope that this second transgenic line will be useful and complement the first 
transgenic line in elucidating autophagic flux during liver carcinogenesis as well as 
other liver diseases.  
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1. The use of zebrafish as a model organism for the study of cancer 
1.1 The use of zebrafish as a model organism in vertebrate developmental 
biology studies 
 The zebrafish (Danio rerio) is an excellent model organism for the study of 
vertebrate developmental biology and genetics due to its superior physical attributes 
when compared with rodent models. External fertilisation and development as well as 
optically transparent embryos allow early developmental processes to be studied 
easily under a dissecting microscope. In addition, traits such as high fecundity with 
the ability of a mating pair producing hundreds of embryos per week and short 
generation times of approximately three months further make possible the use of 
zebrafish for genetics analyses. Moreover, its ease of breeding and small size facilitate 
animal husbandry, and its low maintenance costs make zebrafish an ideal organism to 
complement the rodents in developmental biology and genetics studies (Dooley and 
Zon, 2000; Wixon, 2000). 
In addition to its physical attributes, the popularity of zebrafish as an 
experimental organism has also led to the development of various experimental 
methods and techniques. Whole-mount in situ hybridisation and the use of anti-sense 
morpholino knockdown in transparent embryos facilitate the study of developmental 
processes in vivo. Forward genetic screens employing ethylnitrosourea (ENU)-
induced point mutations allow the zebrafish to be used for screening developmental 
mutants and identifying genes involved in early development for further analyses 
(Driever et al., 1996; Haffter et al., 1996). Although other model organisms such as 
Drosophila and Caenorhabditis elegans are also amendable to large scale screens, the 
absence of vertebrate-specific organs such as kidney and neural crest cells make them 





organs. The zebrafish is also amendable to reverse genetics via an approach known as 
targeting-induced local lesions in genomes, or TILLING, which is adapted from plant 
genomics studies (McCallum et al., 2000). DNA from progeny derived from ENU-
mutagenised parents is sequenced to look for mutations that are present in a gene-of-
interest. Progeny identified to carry the desired mutations are then propagated to 
maintain the line to study the function of the gene-of-interest. Furthermore, 
fluorescent proteins can be expressed in specific organs in order to study their 
development over time by placing the gene encoding fluorescent proteins under the 
control of organ-specific promoters (Higashijima et al., 1997; Long et al., 1997). This 
is especially useful in early development when the larvae are largely transparent 
which facilitates the observation of the organ under study. This method will also 
allow specific genes-of-interest to be expressed under the control of a specific 
promoter to study their function.   
Moreover, efforts have been made to map zebrafish genes onto chromosomes 
by both genetic and physical mapping (Geisler et al., 1999; Hukriede et al., 1999; 
Postlethwait et al., 1998). With advances in sequencing technologies, the zebrafish 
genome sequence is also made available as well for positional cloning. In spite of the 
large evolutionary distance between zebrafish and human, the syntenic relationship 
between their genomes further allow the use of the zebrafish in the identification of 
gene functions of unknown genes in both zebrafish and humans (Barbazuk et al., 
2000).  
In all, these attributes of the zebrafish has positioned it to overcome the 
shortcomings of mouse models as well as made it relevant in developmental biology 






1.2 The use of zebrafish as a model organism in cancer studies 
 Fish has been used to study cancer since the early 1900s (Stern and Zon, 2003). 
Early studies involving Xiphophorus, or swordtail fish, ascertained the existence of an 
oncogene which is the causative agent of malignant melanoma in the species 
(Wittbrodt et al., 1989). The oncogene, now known as the Xiphophorus melanoma 
receptor kinase gene or Xmrk, is homologous to the human Epidermal Growth Factor 
(EGF) receptor, and is found to be masked by its tumour-suppressor at a separate 
locus and studies have shown that it plays an important role in elucidating the 
functional roles of receptor tyrosine kinases in tumourigenesis (Wittbrodt et al., 1989; 
Wittbrodt et al., 1992). Over the years, other fishes such as the medaka (Oryzias 
latipes) and zebrafish are also used in carcinogenicity testing (Law, 2001).  
 The zebrafish has been most appropriately used as a model organism for the 
study of cancer (Amatruda et al., 2002; Feitsma and Cuppen, 2008; Stoletov and 
Klemke, 2008). First used as a chemical carcinogenesis model, the zebrafish 
developed mainly hepatic neoplasms after exposure to the carcinogen 
diethylnitrosamine (Stanton, 1965). More recent studies further showed that the 
zebrafish is capable of developing other types of neoplasms depending on the types of 
chemical carcinogens used and developmental stage at which they were exposed to 
(Spitsbergen et al., 2000a, b). Furthermore, it has been shown that the tumours that 
developed from such exposure were very similar to human tumours at a histological 
level, lending support to the use of zebrafish as a model to study chemically-induced 
cancer (Amatruda et al., 2002; Spitsbergen et al., 2000a). Apart from histological 
similarities between zebrafish and human tumours, comparisons between human and 
zebrafish liver cancer gene signatures revealed significant conservation between the 





carcinogenesis between the two (Lam and Gong, 2006; Lam et al., 2006). The ease of 
housing and processing zebrafish in large numbers for such studies enables these 
studies to generate data with greater statistical powers than mammalian cancer studies 
involving mice and rats (Stern and Zon, 2003). Despite the low cost and technical 
simplicity of chemical carcinogenesis, the low incidence of tumour occurrence 
coupled with late tumour onset and heterogeneity and variability of tumour genetic 
background and location make chemical carcinogenesis a less popular means of 
studying cancer in zebrafish.    
 As the zebrafish is amendable to both forward and reverse genetics in the 
study of vertebrate developmental biology and genetics, these techniques can also be 
adapted to study cancer, and discover and analyse existing and novel oncogenes and 
tumour suppressors in zebrafish. Forward genetic screens were carried out to look for 
mutants displaying phenotypes related to cancer, such as proliferation defects which 
identified mutants with loss-of-function in bmyb and separase (Shepard et al., 2007; 
Shepard et al., 2005). Tp53 mutants were also isolated in reverse genetic screens 
utilising ENU-induced mutagenesis and were found to be involved in the 
development of malignant peripheral nerve sheath tumours (Berghmans et al., 2005).  
Xenotransplantation of mammalian cancer cells from various sources into 
zebrafish of different developmental stages were also performed successfully with 
excellent results. Such studies were useful in delineating the dynamics of 
microtumour formation, angiogenesis and vasculature pruning, as well as cellular 
invasion and metastasis in vivo (Feitsma and Cuppen, 2008; Stoletov and Klemke, 
2008). Stoletov et al. studied how expression of RhoC and VEGF by human cancer 
cells aid in their metastasis, with RhoC expression inducing an amoeboid-type of 





and dynamic membrane blebbing and protrusions, and VEGF expression inducing 
vessel permeabilisation and vessel remodelling to aid the intravasation of cancer cells 
into the remodelled blood vessels (Stoletov et al., 2007).   
The technique of generating transgenic zebrafish with the ability to control the 
expression of various genes in the study of gene function can also be extended to the 
study of oncogenes and tumour suppressors. Through the use of tissue-specific 
promoters, one can control the expression of oncogenes or mutant tumour suppressors 
in a tissue-specific manner. Transgenic zebrafish expressing gene fusions of these 
genes-of-interest with fluorescent proteins can be generated in order to select stable 
transgenic progeny, and more importantly, to facilitate in vivo monitoring and 
imaging of cells expressing these gene fusions (Stoletov and Klemke, 2008). 
Langenau et al. made use of this strategy to over-express human cmyc under the 
control of the zebrafish rag2 promoter, and obtained transgenic zebrafish over-
expressing cmyc in T-cells with the concomitant development of T-cell acute 
lymphoblastic leukaemia (Langenau et al., 2003). Other transgenic zebrafish over-
expressing activated BRAF, zebrafish bcl2 and activated human kRASG12D among 
others were also developed and they provided ample opportunities for studying the 
mechanisms of oncogene-driven carcinogenesis and the cross-talk among different 
signalling pathways (Amatruda and Patton, 2008; Langenau et al., 2005b; Langenau 
et al., 2007; Patton et al., 2005).  
Moreover, these models are amendable to pharmacological testing and novel 
drug discovery as the zebrafish embryos and larvae are permeable to many water-
soluble compounds and they can be arrayed in a manner that facilitates high-
throughput screening. Moreover, screens for compounds and chemicals that can exert 





lines as they are able to suppress the disease phenotype in a whole organism in vivo 
and they do not harbour any target bias (Stern and Zon, 2003). Compounds that are 
active in suppressing cancer phenotypes can be identified for further testing, as 
evidenced by screens for anti-angiogenic compounds (Wang et al., 2010; Zhang et al., 
2009). 
 
1.3 Generation of inducible Xmrk and cmyc driven liver cancer models  
1.3.1 The use of inducible promoter systems to control transgene expression 
 Langenau et al. generated the first transgenic zebrafish expressing human 
cmyc under the control of a zebrafish tissue-specific mitfa promoter which made for 
an excellent model to study the mechanism of cmyc-driven T-cell acute lymphoblastic 
leukaemia (Langenau et al., 2003). However, the authors found that the resultant 
transgenic zebrafish showed rapid onset of cancer that displayed efficient invasion 
and metastasis to other tissues and organs, leading to early lethality and requiring in 
vitro fertilisation for line maintenance. To overcome this problem, the same authors 
made use of the Cre/lox and heat shock promoter systems to control the expression of 
the cmyc oncogene (Feng et al., 2007; Langenau et al., 2005a). Initially the Cre/lox 
system displayed low disease penetrance when the conditional transgenic progeny 
carrying germline insertion of the construct rag2-loxP-dsRED2-loxP-EGFP-mMyc 
were injected with the Cre mRNA; with the complementation of the heat shock 
promoter controlling Cre expression, a higher rate of recombination events took place 
after heat shock which resulted in more progeny expressing the rag2-EGFP-mMyc 
cassette and thus, developing T-cell acute lymphoblastic leukaemia. Thus the spatio-
temporal expression of transgenes can be controlled in conditional transgenic lines 





 To follow tumour initiation, progression and even regression in the zebrafish, 
one must be able to control the switching on or off of oncogene expression (Feitsma 
and Cuppen, 2008). The tetracycline-responsive systems, which include the Tet-on 
and Tet-off systems, can exert such control over transgene expression. The 
tetracycline-responsive system was first established and demonstrated in Hela cells to 
control transgene expression (Gossen and Bujard, 1992). In the early versions of the 
system, the tetracycline repressor (tetR) from the tetracycline-resistant operon in 
Escherichia coli was fused to the activating domain of the virion protein 16 from the 
herpes simplex virus to form a tetracycline-controlled transactivator. tetR then 
activates transcription from a minimal promoter generated by the combination of 
human cytomegalovirus promoter and tet operator sequences. The isolation of a 
mutant tetR, known as rtTA, that requires the presence of doxycycline (Dox) in order 
to bind to and activate transcription of the minimal promoter and further refinements 
to the promoter system increase its efficiency and reduce its background activities and 
further gave birth to the Tet-on and Tet-off systems (Urlinger et al., 2000). This 
system will allow us to control not only the expression of the gene, but also the degree 
of expression by controlling Dox concentration. 
 
1.3.2 The use of transposable elements to generate transgenic zebrafish 
The standard method of generating transgenic zebrafish is via the injection of 
DNA constructs containing gene expression cassettes consisting of a promoter, a 
transgene and polyA signals into one-cell stage embryos in the hope that the construct 
will be taken up and integrated into the genome of the injected embryos for germline 
transmission. This method has been the sole method in early transgenic fish studies 





employing this method is often less than satisfactory, with germline transmission rates 
of less than 10%. Hence there is a need to increase transgenesis rates to facilitate 
transgenic zebrafish generation. The reported use of the Tol2 transposition system 
from medaka and Sleeping Beauty transposition system from salmonid provided a 
new impetus in generating transgenic zebrafish with significantly higher transgenesis 
and gene expression rates (Davidson et al., 2003; Kawakami et al., 2000). 
Transposable elements can be found in genomes of most vertebrates and are 
composed of transposon DNA and a recombinase-coding DNA sequence that is 
involved in transposon trans-activation (Ivics et al., 2004). Recently, the Activator 
(Ac)/Dissociation (Ds) transposition system first isolated in maize by McClintock was 
found to work in zebrafish with comparable transgenesis and gene expression rates 
(Emelyanov et al., 2006; McClintock, 1950). This study also showed that the Ac/Ds 
transposable element is versatile enough to be active in zebrafish and human cells, 
eliminating the requirement for host cell-specific factors for transposition to occur. 
Furthermore, our laboratory recently reported the successful use of the Ac/Ds 
transposable element in the generation of transgenic zebrafish expressing zebrafish 
kRASV12 under the control of the liver-specific fabp10 promoter in modelling 
oncogene-driven liver cancer (Her et al., 2003; Nguyen et al., 2011).  
 
1.3.3 Xmrk and cmyc driven liver cancer models  
 Our laboratory has also successfully made use of the Tet-on system to 
generate transgenic zebrafish with inducible, liver-specific expression of oncogenes to 
model liver cancer. In our zebrafish, a liver-specific fabp10 promoter was used to 
drive the constitutive expression of the rtTA transactivator, which will activate 





separate construct in the presence of Dox. We used two different oncogenes to model 
liver cancer, namely the Xiphophorus melanoma receptor kinase gene or Xmrk, an 
Epidermal Growth Factor receptor (EGFR) homologue, and mouse cmyc (Huang et al., 
2011). Xmrk was first isolated in Xiphophorus, which was the main causative agent 
for melanoma development in the fish species. Xmrk was found to harbour activating 
mutations in the extracellular domain, explaining its tumourigenicity in vitro and in 
vivo (Winnemoeller et al., 2005). The suitability of using Xmrk to drive liver 
carcinogenesis was further supported by studies implicating dysregulated EGFR 
signalling in human hepatocellular carcinoma or HCC (Berasain et al., 2009). It is 
noteworthy to point out that the EGFR pathway is chronically stimulated during 
inflammation in the liver following injury and that tumourigenesis is favoured in the 
backdrop of inflammation. Further studies implicated the over-expression of EGFR 
and its ligands in human HCC (Avila et al., 2006; Berasain et al., 2007; Breuhahn et 
al., 2006; Castillo et al., 2006). Thus it would be interesting to uncover the role 
chronic Xmrk over-expression plays in liver carcinogenesis.  
 We also generated Dox-inducible liver-specific over-expression of mouse 
cmyc. Initially isolated from chicken DNA, cmyc is the cellular homologue of the v-
myc oncogene found in avian myelocytomatosis retrovirus MC29 (Vennstrom et al., 
1982). The oncogenic potential of cmyc was first demonstrated by its involvement in 
the progression of human Burkitt’s lymphoma, due to a translocation event between 
chromosome 8 and one of the three chromosomes containing genes encoding 
immunoglobulins (Spencer and Groudine, 1991). cmyc encodes a transcription factor 
that heterodimerises with its partner protein MAX via interaction with its carboxy-
terminal basic-helix-loop-helix-zipper domain. The heterodimer binds to E-box-





Eisenman, 1991; Eilers and Eisenman, 2008; Pelengaris et al., 2002). cmyc expression 
is positively correlated with cell growth and proliferation by promoting cell-cycle 
progression; it also inhibits cellular terminal differentiation of most cell types as well 
as sensitises cells to apoptosis (Amati, 2001; Amati et al., 1998; Dang, 1999; Eilers, 
1999). In addition, cmyc expression is also involved in cellular reprogramming to 
form induced pluripotent stem cells (Eilers and Eisenman, 2008). In light of these, it 
is of interest to uncover links that connect dysregulated cmyc expression and 
carcinogenesis. Early studies using mouse models provided evidence linking 
hepatocyte-specific cmyc over-expression with chronic hepatic proliferation and 
increased incidence of cancer, and it potentiates transforming growth factor (TGF)-α 
in the development of hepatocellular carcinoma (Calvisi and Thorgeirsson, 2005). 
However, the role of dysregulated cmyc expression in carcinogenesis is still elusive, 
although several hypotheses have been proposed (Dang et al., 2005; Eilers and 
Eisenman, 2008; Pelengaris et al., 2002).   
 These two models that we have generated will provide us with ample material 
to study the roles of oncogene-driven liver carcinogenesis, and to study the intricate 
cross-talk between various signalling pathways. They also represent good models for 
chemical and drug screens that target both EGFR and cmyc signalling pathways in a 
whole organism.    
 
2. An introduction to autophagy and its involvement in cancer 
2.1 Autophagy as a basal and inducible cellular process 
   Autophagy is a ubiquitous cellular process that involves the delivery of 
cellular cytoplasmic components for degradation in the lysosome. Early studies led to 





mediated autophagy, microautophagy and macroautophagy. They differ with respect 
to the method of sequestering and delivering cytoplasmic components to the lysosome 
for degradation and their physiological functions (Levine and Kroemer, 2008). In 
microautophagy, cytoplasmic components are taken up by protrusion, septation or 
invagination of the vacuolar membrane in the yeast or the lysosomal membrane in 
eukaryotes; whereas chaperone-mediated autophagy requires chaperones to facilitate 
the translocation of unfolded, soluble proteins across the lysosomal membrane (Wang 
and Klionsky, 2003; Yang and Klionsky, 2009). In macroautophagy, double-
membrane vesicles called autophagosomes sequester cytoplasmic components, which 
then fuse with lysosomes with the concomitant delivery of the inner single-membrane 
vesicles for lysosomal degradation and recycling of resultant nutrients (Yang and 
Klionsky, 2009). We will only focus on macroautophagy (referred to as autophagy 
hereafter) in this dissertation.  
 Autophagy is an evolutionarily conserved cellular process involved in the 
degradation of a cell’s cytoplasm, long-lived proteins and organelles in response to 
cellular stressors such as starvation. Autophagy is also involved in the degradation of 
damaged or superfluous organelles and proteins and protein aggregates, in addition to 
its role in regulating cellular homeostasis at a basal level (Klionsky, 2007; Mizushima 
et al., 2008). The ability of autophagy to carry out large-scale degradation of cellular 
components requires it to be tightly controlled, as unregulated autophagy can have 
catastrophic consequences. Due to its far-reaching effects in regulating cellular 
turnover and homeostasis, autophagy deregulation is found to be implicated in various 
diseases such as neurodegeneration, myopathies, infection and immunity, as well as 





 Autophagy was first identified in mammalian cells by Christine de Duve in the 
1950s as part of a lysosomal degradative mechanism (Klionsky, 2007). Subsequent 
genetic screens for yeast mutants affecting protein turnover led to the identification of 
autophagy-related (Atg) genes and their protein products that are crucial for the 
autophagy process (Yang and Klionsky, 2009). To date, more than 30 Atg genes have 
been identified in yeast, and more than a dozen orthologues in higher organisms have 
also been identified (Kourtis and Tavernarakis, 2009; Rubinsztein et al., 2007).  
  
2.2 Molecular machinery of autophagy 
 Autophagy is a multi-step process. Autophagy induction leads to the formation 
of a phagophore that undergoes nucleation and elongation to form a double-
membrane vesicle called the autophagosome which sequesters cytoplasmic 
components in the process. The autophagosome subsequently fuses with endosomes 
forming amphisomes, or with lysosomes forming autolysosomes where the 
sequestered materials are then released into the lysosome to be degraded by lysosomal 
enzymes and the resultant amino acids and other nutrients are subsequently reused for 
use by the cell (Klionsky, 2007; Levine and Kroemer, 2008). This section serves to 
briefly summarise the current knowledge of the molecular mechanisms of autophagy.  
Induction of autophagy requires the activity of Atg1, a serine/theronine kinase, 
which is found in a complex with Atg13 and Atg17 (Kabeya et al., 2005; Kamada et 
al., 2000; Matsuura et al., 1997). Studies have demonstrated that the formation of this 
protein kinase complex is positively correlated with an increase in autophagic activity. 
Uncoordinated 51-like kinases (Ulk) 1 and 2 are mammalian homologues of Atg1, 
while FIP200 has been recently identified to form a complex with Ulk1 and was 





Hara et al., 2008; Yan et al., 1998). Furthermore, studies by Jung et al. provided 
evidence of the existence of a functional mammalian homologue of Atg13, proving 
that the induction machinery is well conserved in higher vertebrates (Jung et al., 
2009).  
Vesicle nucleation requires the activity of a protein complex comprising a 
class III phosphatidylinositol 3-kinase (PI3K) Vps34, Vps15, Atg6 and Atg14 (Levine 
and Kroemer, 2008). In yeast, Vps34 activity is regulated by its partner Vps15, and 
Atg14 serves to specify the complex for autophagy (Obara et al., 2006; Stack et al., 
1995). Vps34 activity is crucial for autophagy and it is thought that the production of 
PI(3)P by Vps34 serves to recruit downstream effectors to the complex for nucleation 
events (Yang and Klionsky, 2009). Similar to yeast, mammalian class III PI3K, 
hVps34 forms a complex with p150, a homologue of Vps15, as well as Beclin1, the 
mammalian homologue of Atg6, and the complex is required for autophagy, proving 
that autophagy is a highly conserved process from yeast to mammals (Liang et al., 
1999; Panaretou et al., 1997; Volinia et al., 1995).   
Expansion of the double-membrane structure requires the activity of two 
ubiquitin-like protein conjugation systems, namely, the Atg12 and Atg8 systems 
(Yang and Klionsky, 2009).  The Atg12 system is found to be essential for 
preautophagosomal membrane formation, while Atg8 conjugation is required for 
formation of complete autophagosomes by mediating membrane tethering and 
hemifusion (Kabeya et al., 2000; Mizushima et al., 2001; Nakatogawa et al., 2007). 
Atg12 is first activated by the E1-like enzyme, Atg7, which is then transferred to the 
E2-like enzyme, Atg10, before being conjugated to Atg5 (Mizushima et al., 1998a). 
Atg12-Atg5 complex then interacts with Atg16 to form a Atg12-Atg5-Atg16 





autophagy (Kuma et al., 2002). Similarly, Atg8 is first cleaved by Atg4, exposing a 
terminal glycine, it is then activated by Atg7, before being transferred to another E2-
like enzyme Atg3 for conjugation to a membrane lipid, phosphotidylethanolamine 
(PE) (Ichimura et al., 2004; Ichimura et al., 2000). Similar to other Atg proteins, 
Atg12 and Atg8 systems remain highly conserved and are functional in mammalian 
autophagy and their mammalian counterparts have been identified and characterised 
such as the mammalian counterpart of Atg16, Atg16L (Mizushima et al., 2003; 
Mizushima et al., 1998b; Mizushima et al., 2002). Similarly, Atg8 has several 
mammalian homologues, namely MAP1LC3 or LC3, GATE16, GABARAP, and 
Atg8L, and they are processed similarly to the yeast Atg8 with LC3 being the most 
abundant in autophagosomal membranes and therefore used as a marker to monitor 
autophagic activity (Hemelaar et al., 2003; Kabeya et al., 2000; Kabeya et al., 2004; 
Tanida et al., 2006). During autophagosomal membrane expansion, both Atg12-Atg5-
Atg16L and LC3-PE conjugates can be found to decorate the autophagosomal 
membrane, with the Atg12-Atg5-Atg16L mostly localised on the outer membrane and 
released from the membrane shortly before or after autophagosome formation while 
LC3-PE was found on both inner and outer membranes (Kabeya et al., 2000; Kirisako 
et al., 1999; Mizushima et al., 2003; Mizushima et al., 2001). LC3-PE found on the 
outer leaflet of the autophagosomal membrane is released from the autophagosomal 
membrane by Atg4 cleavage, while those found on the inner leaflet remains in the 
autophagosome and is delivered together with the sequestered materials to the 
lysosome for degradation. The reversible process of Atg8-PE conjugation, where 
Atg4 can also liberate Atg8 from PE, allows Atg8 to be recycled and used in another 
conjugation reaction, allowing efficient autophagy to occur (Kirisako et al., 2000). It 





lipidation and for specifying the site of LC3 lipidation in mammalian autophagy 
(Fujita et al., 2008).  
Other Atg proteins not mentioned above play other roles that are equally 
important to autophagy. An integral membrane protein Atg9 is thought to play the 
role of trafficking membrane to the forming autophagosome (He et al., 2006; Noda et 
al., 2000). Atg9 movement to the forming autophagosome requires Atg23 and Atg27, 
which function in a heterotrimeric complex, while retrieval of Atg9 from the forming 
autophagosome requires the combined action of Atg2 and Atg18 in addition to the 
Atg1-Atg13-Atg17 complex (Legakis et al., 2007; Reggiori et al., 2004; Yen et al., 
2007). Atg11 and Atg17 may act as scaffold proteins in the recruitment of Atg 
proteins (Yang and Klionsky, 2009). Atg15 is thought to exert lipase activity due to 
the presence of a lipase active site motif (Teter et al., 2001). Yeast Atg22 was found 

















Figure 1 Schematic illustration of the autophagy pathway and its core machinery 
in mammalian cells. Autophagy is a multi-step process with the involvement of 
several Atg proteins at each step. Figure reproduced from Levine and Kroemer 








2.3 Regulation of autophagy 
 The Target of Rapamycin (TOR) kinase is the key regulator of autophagy in 
eukaryotes. Apart from regulating autophagy, it also regulates various cellular 
processes involved in cell growth such as transcription, translation, cell size and 
cytoskeletal organisation (Schmelzle and Hall, 2000). Mammalian TOR (mTOR) 
signalling is crucial in the integration of various cellular signals and cell stressors 
(Corradetti and Guan, 2006). mTOR can be incorporated into two TOR complexes, 
mTORC1 and mTORC2, where they phosphorylate different cellular targets and 
possess different functions and different sensitivities to rapamycin (Jacinto et al., 
2004; Loewith et al., 2002). mTORC1 is rapamycin-sensitive and acts as a potent 
inhibitor of autophagy, where it inhibits autophagy in the presence of growth factors 
and nutrients (Levine and Kroemer, 2008). Growth factors stimulate receptor tyrosine 
kinases, where they activate mTORC1 via PI3K-Akt signalling which in turn, inhibit 
autophagy (Esclatine et al., 2009; Levine and Kroemer, 2008; Lum et al., 2005). 
mTOR senses changes in cellular energy via the 5’-AMP-activated protein kinase 
(AMPK). Low energy status in the cell is represented by a high AMP to ATP ratio, 
and activates AMPK where it inhibits mTOR signalling to activate autophagy 
(Corradetti et al., 2004; Meijer and Codogno, 2011). mTOR inhibits autophagy by 
phosphorylating Atg13 in the Atg1-Atg13-Atg17 complex; hyper-phosphorylated 
Atg13 has reduced affinity for Atg1 and Atg17, leading to reduced Atg1-Atg13-Atg17 
complex formation and concomitantly, reduced autophagy induction (Klionsky, 2005).   
 Other regulatory molecules that exert influence on autophagy also include the 
eukaryotic initiation factor 2α (eIF2α) which responds to stressors like nutrient 
deprivation, and endoplasmic reticulum (ER) stress, mitogen-activated (MAP) kinases, 





(DAPk), the heterotrimeric  G protein Gi3, tumour suppressor p53 and others 
(Esclatine et al., 2009).  
 Pharmacological agents that target mTOR as well as the phosphotidylinositol 
3-kinases (PI3K) involved in autophagy regulation can be used to either induce or 
inhibit the autophagic process. As mentioned above, rapamycin and its analogues 
such as everolimus can be used to induce autophagy by relieving mTOR-induced 
inhibition (Rubinsztein et al., 2007). 3-Methyladenine, a potent PI3K inhibitor, can 
also be used to inhibit autophagy by inhibiting the activity of class III PI3K 
(Blommaart et al., 1997; Petiot et al., 2000; Seglen and Gordon, 1982). Lysosomal 
proton pump inhibitors such as bafilomycin A1 and lysosomotropic alkalines such as 
chloroquine can also be used to inhibit autophagy effectively (Levine and Kroemer, 
2008).  
Apoptosis is a programmed cell death process discovered during insect 
metamorphosis and during embryogenesis and development of both vertebrates and 
invertebrates (Glucksmann, 1965; Lockshin and Williams, 1965a, b, c; Saunders, 
1966). It is characterised by caspase activation, poly (ADP-ribose) polymerase I 
(PARP1) proteolysis and DNA fragmentation cuminating in cell shrinkage, chromatin 
condensation and apoptotic body formation  (Giansanti et al., 2011). It operates via 
two pathways, extrinsic and intrinsic, with the extrinsic pathway activated via 
receptor binding of molecules belonging to the Tumour Necrosis Factor (TNF) family, 
and the intrinsic pathway activated by stimuli converging and acting on the 
mitochondria. Both pathways culminate in the activation of caspases, which serves to 
degrade cellular components at the final step of apoptosis, following which the 
degraded components are engulfed by phagocytes to prevent an inflammatory 





The intimate relationship between apoptosis and autophagy was discovered 
when Boya et al. reported that mammalian cells were observed to undergo apoptosis 
when they were devoid of nutrients and when autophagy was inhibited through the 
use of chemical inhibitors or genetic silencing by siRNAs (Boya et al., 2005). Boya et 
al. further observed that cells with autophagic vesicles were able to recover when 
cultured under optimal conditions following nutrient deprivation, although cells with 
disrupted mitochondrial transmembrane potential were still committed to die when 
cultured under the same conditions, strongly suggesting a pro-survival role of 
autophagy under cellular stress. However, Notte et al. noted that in the event that the 
stress is too severe or the duration of the stress is too long, autophagy may also 
participate in cell death on observations that numerous autophagic vesicles were 
found in dying cells (Notte et al., 2011). More studies need to be performed to 
determine if autophagy does indeed participate actively in cell death either on its own, 
or together with other cell death mechanisms, or if these observations merely a 
consequence of a failed attempt to preserve cell viability in times of stress (Levine 
and Yuan, 2005).  
 Further studies revealed that Bcl-2 family members were found to regulate 
both pathways: anti-apoptotic Bcl-2 and Bcl-XL were found to bind to and inhibit 
Beclin1 through the Beclin1 BH3 domain possibly to inhibit autophagy (Maiuri et al., 
2007; Zhou et al., 2011).  The involvement of Atg5 in both autophagy and apoptosis 
further supports the intricate cross-talk between the two processes: tumour cells with 
atg5 over-expression were found to be more susceptible to apoptotic stimuli, while 
silencing of atg5 results in partial resistance to chemotherapy (Yousefi et al., 2006). 
This intricate relationship between autophagy and apoptosis is further convoluted by 





as well as enforced autophagy leading to cell demise in apoptosis-resistant cells either 
through cooperation with other cell death mechanisms or massive autophagy-induced 
cell death (Chen et al., 2010; Scarlatti et al., 2009; Shen and Codogno, 2011; Xie et al., 
2011; Zhivotovsky and Orrenius, 2010). Thus it would be interesting to delve more 
deeply into the relationship of autophagy and apoptosis and to make use of this 



















Figure 2 Regulation of mammalian autophagy. The intricate relationship between 
various signalling pathways and autophagy regulation is depicted in the figure above. 
















2.4 The use of EGFP-LC3 and mRFP-EGFP-LC3 to study autophagy in vivo 
 The past decade has seen an exponential increase in the research on autophagy, 
especially its implication in diseases hence there is a need to establish techniques to 
study autophagy both in vitro and in vivo. The gold standard of analysing autophagic 
activity requires the use of electron microscopy to identify autophagosomes and 
autolysosomes (Mizushima et al., 2010). However such a method is both time 
consuming and requires expertise in the correct identification of autophagic vesicles. 
Thus there is a need to establish a more reliable and accessible method of analysing 
autophagy status. The finding that LC3, the mammalian homologue of Atg8, 
undergoes PE lipidation for its localisation to autophagosomes provides an 
opportunity to detect autophagic activity. LC3 can be found in mammalian cells in 
two forms, LC3-I and the PE-conjugated LC3-II. LC3-I is found in the cytosol while 
LC3-II is usually found to be associated with autophagosomal membranes and its 
formation is positively correlated with autophagosome formation and thus autophagic 
activity (Kabeya et al., 2000). Thus immunoblotting of LC3-I and LC3-II provide an 
easy read-out of autophagic activity in both in vitro and in vivo experimental 
conditions (Klionsky et al., 2008; Mizushima et al., 2010).  
 The introduction of protein fusions to fluorescent proteins further allow 
autophagic analyses to be easily performed using fluorescent microscopes in real time. 
The use of EGFP-LC3 fusion protein was first established by Kabeya et al. where 
they reported the association of LC3-II with autophagosomal membranes forming 
discrete EGFP puncta. They further established that LC3-I was freely available in the 
cytosol forming a diffuse cytoplasmic distribution (Kabeya et al., 2000). This study 
establishes the use of EGFP-LC3 to analyse autophagic activity, where an up-





autophagosomes. The intracellular localisation of EGFP-LC3 thus becomes a 
complementary method for the analyses of autophagic flux in addition to 
immunoblotting for LC3 (Kabeya et al., 2000). Since then, EGFP-LC3 is used to 
study autophagy dynamics in a variety of in vitro conditions using various cell lines as 
well as in the generation of transgenic mice to study autophagic dynamics in a variety 
of conditions such as starvation (Mizushima et al., 2004).  
 As autophagosome formation is an intermediate step in a highly dynamic 
cellular process, EGFP-LC3 puncta observed at any specific time point usually 
reflects the delicate balance between the rate of autophagosome formation and the rate 
at which they are converted to autolysosomes (Mizushima et al., 2010). As such, it 
would be more appropriate to measure autophagic flux to determine cellular 
autophagic activity. Autophagic flux refers to the dynamic process of autophagosome 
formation, delivery of engulfed cellular substrates to the lysosome and subsequent 
degradation of the substrates within the lysosome. One method of measuring 
autophagic flux is to quantify EGFP-LC3 puncta numbers present in cells, as 
increased autophagic activity often leads to increased autophagosome formation and 
therefore, EGFP-LC3 puncta formation. However, a major pitfall exists as increased 
puncta numbers may also be due to reduced autophagic degradation that leads to an 
accumulation of autophagosomes. Therefore the number of EGFP-LC3 puncta that 
can be quantified does not correlate to cellular autophagic activity per se and several 
other assays are required in addition to observing EGFP-LC3 puncta formation to 
determine autophagic flux.  
 Another useful assay to measure autophagic flux was developed based on the 
concept of lysosomal quenching of GFP fluorescence. As mentioned, 





engulfed cellular substrates. However, the low pH achieved through autophagosome-
lysosome fusions quench GFP fluorescence, making it difficult to trace EGFP-LC3 
delivery to lysosomes; this also hampers efforts to demonstrate the co-localisation of 
EGFP-LC3 puncta with lysosomes (Bampton et al., 2005; Kabeya et al., 2000). On 
the other hand, RFP exhibits stable fluorescence in acidic compartments making it 
useful in labelling acidic autophagic vesicles. A novel reporter consisting of 
monomeric RFP (mRFP) and EGFP fused to LC3 was developed to study 
autophagosome-lysosome fusion as well as to provide a means of measuring 
autophagic flux (Kimura et al., 2007). Using this novel construct, autophagosomes are 
labelled yellow (due to presence of both GFP and RFP) and autolysosomes are 
labelled red and autophagic flux can be measured simply by observing the ratio of 
both yellow and red signals. Increases in autophagic flux are indicated by increases in 
both yellow and red puncta while blockages in fusion and maturation of 
autophagosomes into autolysosomes are indicated by increases in yellow puncta 
without concomitant increases in red puncta, making it easier to study autophagic flux 
in real time. We can accurately study autophagic activity with the use of the mRFP-
EGFP-LC3 reporter together with other assays.    
 
2.5 Autophagy in cancer 
 Dysregulated autophagy is implicated in various diseases such as 
neurodegeneration, myopathies, infection and immunity, as well as cancer (Levine 
and Kroemer, 2008; Mizushima et al., 2008). Among them, the role of autophagy in 
cancer still remains elusive. The first evidence linking autophagy as a tumour 
suppression mechanism came from the discovery that Atg6/Beclin1 is a 





1999; Qu et al., 2003; Yue et al., 2003). Other studies implicating Atg4C, Atg5 and 
Atg7 deficiencies to increased rates of tumourigenesis as well as the findings that 
Beclin1 cofactors act as tumour suppressors further demonstrated the tumour 
suppressive function of autophagy (Brech et al., 2009; Marino et al., 2007; Mathew et 
al., 2007b; Takamura et al., 2011). Further studies revealed that most oncogenes like 
class I PI3K and Akt inhibit autophagy while tumour suppressors such as phosphatase 
and tensin homologue (PTEN) and tuberous sclerosis complex 1 and 2 (TSC1 and 
TSC2) induce autophagy (Maiuri et al., 2009). Moreover, autophagy may also be 
required to kill tumour cells efficiently in certain circumstances as shown by Giaccia 
and colleagues where they demonstrated that addition of a compound STF-62247 
induced autophagy and vacuolisation in von Hippel-Lindau (VHL)-deficient renal cell 
carcinoma cells (Turcotte et al., 2008). 
On the other hand, autophagy induction may represent a means for tumour 
cells to survive various cellular insults such as hypoxic conditions, metabolic stress 
and chemotherapeutic stress (Chen and Debnath, 2010; Degenhardt et al., 2006). 
Although autophagy may have tumour suppressive functions, autophagy is still 
required for the survival of established tumour cells in response to various stresses. As 
a result of their higher proliferation rates, tumour cells have higher demands for 
nutrients and oxygen and they increase their autophagic activity in order to survive 
this metabolic stress (Degenhardt et al., 2006). Similarly, tumour cells found in the 
interior of poorly vascularised tumours survive hypoxic conditions by up-regulating 
their autophagic activity, in turn protecting them from apoptosis and necrosis. 
Furthermore, autophagy may confer pro-survival benefits in metastasising tumour 
cells by protecting them from anoikis (Fung et al., 2008). Autophagy also serves to 





provided evidence that siRNA-induced inhibition of autophagy re-sensitised cancer 
cells to radiation-induced cell death, suggesting that cancer cells co-opt autophagy as 
a cell survival mechanism, which is in line with its function of promoting cell survival 
during periods of stress (Apel et al., 2008).  Thus autophagy is likened to a double-
edged sword, as autophagy has both tumour suppressive and pro-tumourigenic 
properties (Mathew et al., 2007a; White and DiPaola, 2009). There is a consensus that 
autophagy as a tumour suppressive mechanism exerts its effects via damage 
mitigation and limiting metabolic stress and genomic instability (Karantza-
Wadsworth et al., 2007; Mathew et al., 2007b). Tumourigenesis is favoured in an 
inflammatory environment, and autophagy serves to limit inflammation and therefore 
exerts its tumour suppressive function (Degenhardt et al., 2006). However, autophagy 
is also co-opted as a survival mechanism by established tumour cells facing hypoxic 
conditions and metabolic stress, enabling long-term cell survival against a backdrop 
of apoptotic defects (Degenhardt et al., 2006; Lum et al., 2005). Autophagy may also 
help tumour cells establish dormancy in the face of severe stress, and the ability to 
regenerate and form viable tumour cells when favourable environmental conditions 
return (White and DiPaola, 2009). Lastly, autophagy may also be up-regulated in 
tumour cells facing therapeutic stress, as demonstrated by Apel et al. (Apel et al., 
2008). Thus it is hypothesised that autophagy be up-regulated during early 
carcinogenesis in order for it to exert its anti-cancer function, while inhibited in extant 
tumours to re-sensitise them to stress and chemo- and radio-therapy. As such, more 
work needs to be done to establish this paradigm as well as to determine the efficacy 








Figure 3 Autophagy in tumourigenesis and anti-cancer therapy. Autophagy is 
likened to a double-edged sword possessing both tumour suppressive and pro-
tumourigenic properties. Autophagy can either promote tumour cell survival or kills 
tumour cells as a result of anti-cancer therapy; hence it is a novel target in anti-cancer 

















3. Rationale of current study 
3.1 Establishing Tg(fabp10:egfp-lc3) and Tg(fabp10:mrfp-egfp-lc3)  transgenic 
zebrafish for studying autophagy 
 The study of autophagy in a model organism has been made possible by the 
use of EGFP-LC3 fusion protein and this was demonstrated by Mizushima et al. when 
they generated the first transgenic mouse with ubiquitous and constitutive expression 
of EGFP-LC3 (Mizushima et al., 2004). Therefore, it is envisioned that the 
establishment of a transgenic zebrafish expressing egfp-lc3 will be useful in the study 
of autophagy in this popular vertebrate model, where little study has been conducted. 
A zebrafish transgenic line with liver-specific egfp-lc3 expression will be generated in 
this study in order to study autophagy in the liver. This makes sense as autophagy was 
first studied in rat livers following glucagon injection and that autophagy plays an 
important role in nutrient and energy metabolism and homeostasis in the liver (Yin et 
al., 2008). In addition, reduced autophagic activity was implicated in liver 
inflammation and carcinogenesis involving alpha-1-antitrypsin deficiency, suggesting 
that functional autophagy is required for proper protein aggregate disposal (Perlmutter, 
2009).  
 To generate a transgenic line with constitutively liver-specific egfp-lc3 
expression, the liver-specific fabp10 promoter will be used to restrict egfp-lc3 
expression to the liver tissue. In order to increase transgenesis and germline 
transmission rates, the Ac/Ds transposition system will be used as well. This 
transgenic line will be useful in studying autophagy in liver development as well as in 
various liver injuries. It will be useful for studying the role of autophagy in liver 
cancer using our liver cancer models, and will also be useful for chemical and drug 





 As a proof of concept, we will also generate a transgenic line with 
constitutively liver-specific mrfp-egfp-lc3 expression. This will be the first attempt in 
generating a transgenic organism expressing this novel reporter. We hope to employ 
this transgenic line in liver cancer study as well as other studies involving liver 
development or liver diseases in the zebrafish. Similar methodology used in the 
generation of the EGFP-LC3 transgenic line will be applied here.  
 
3.2 Establishing the role of autophagy in liver cancer 
Studies have also demonstrated both pro-tumourigenic and anti-tumourigenic 
functions of autophagy in liver cancer. Mice heterozygous for Beclin1 have a higher 
propensity to develop spontaneous hepatocellular carcinoma (HCC), suggesting an 
anti-tumourigenic function (Qu et al., 2003). Ding et al. demonstrated in their study 
that HCC cell lines have lowered levels of Atg gene expression as well as autophagic 
activity compared to normal hepatic cell lines; they also found reduced levels of 
Beclin1 mRNA and protein levels in HCC tissue samples compared to adjacent non-
tumourigenic tissues from the same patient. They also demonstrated that lowered 
autohagic activity in the malignant cell lines and HCC tissues was especially 
prominent when anti-apoptotic proteins such as Bcl-XL was over-expressed, further 
suggesting that autophagy defects synergised with apoptotic defects in promoting 
liver carcinogenesis, suggesting that antophagy has an anti-tumourigenic function 
(Ding et al., 2008). In contrast, Longo et al. demonstrated that autophagy functions as 
a survival mechanism in liver cancer cells and protected them from anthocyanin-
induced apoptosis, thus suggesting a pro-tumorigenic role of autophagy (Longo et al., 
2008). As can be seen, the role of autophagy in liver cancer is currently not well 





suppressive function during early stages of carcinogenesis while it is co-opted by 
extant tumour cells as a means to survive metabolic and chemo- or radio-therapeutic 
stress. Thus we would like to examine this phenomenon using our zebrafish liver 
cancer models. In order to do this, we will examine the autophagic flux during liver 
tumour initiation, progression and regression using our zebrafish liver tumour models. 
We hope to derive more detailed information on the involvement of autophagy in 
liver cancer, and hope that this information will help in designing combinatorial 
chemotherapy for liver cancer patients using autophagy inducers or inhibitors at the 
appropriate stages of treatment together with established chemotherapeutic drugs for 
liver cancer.  
 
3.3 Objectives of the study 
 We would like to propose the following objectives for this study:  
1. Validation of conservation of autophagic machinery in the zebafish  
2. Establishment and characterisation of a zebrafish transgenic line with 
constitutively liver-specific egfp-lc3  
3. Establishment and characterisation of a zebrafish transgenic line with 
constitutively liver-specific mrfp-egfp-lc3 expression  
4. Analysing autophagic flux in zebrafish transgenic lines with inducible liver 
tumour zebrafish models by crossing egfp-lc3 and oncogene-expressing 
transgenic lines 
We hope that by achieving these objectives we will be able to prove our 
hypothesis that autophagy serves an anti-cancer function in the early stages of cancer 
and it may be co-opted by cancer cells as a cell survival mechanism at later stages. 





therapy using existing drugs and autophagy inducers or inhibitors at appropriate 





































1. Zebrafish care and maintenance and tissue collection 
1.1 Zebrafish maintenance 
 Wild type and transgenic adult zebrafish were maintained in the National 
University of Singapore Aquarium at Block S2 Level 2 according to the method as 
described in the Zebrafish Book available online at the Zebrafish Information 
Network (ZFIN) (http://zfin.org/zf_info/zfbook/zfbk.html) (Westerfield, 2000) and in 
compliance with the Institutional Animal Care and Use Committee (IACUC) 
guidelines. Fish were kept in the aquarium with a photoperiod of 14 h light, 10 h dark. 
Fish were fed brine shrimp (World Aquafeeds, USA) twice a day, with additional 
flakes being fed in the late afternoon during the spawning period. 
 
1.2 Zebrafish spawning and embryo collection 
 To collect embryos, breeding adult fish were separated into pairs with each 
pair being separated using a divider in a tank the night before. Spawning was induced 
by the removal of the divider and allowing the fish to mate on the following morning. 
Following that, the breeding pair was removed and the embryos that were found on 
the bottom of the tank were drained using a sieve and placed in a petri dish containing 
egg water (final concentration of 60 µg/ml sea salt dissolved in RO water) and 
methylene blue (final concentration of 0.0002 %), and staged accordingly (Kimmel et 
al., 1995). The required developmental stages were presented as hours post-
fertilisation (dpf). Embryos were placed in an incubator with a constant temperature 
of 28.5 °C to facilitate staging. 
To rear embryos, embryos were kept in the incubator with daily changes of 
egg water and removal of dead embryos and larvae until they were approximately 4 
dpf, before they were transferred into larger tanks containing egg water only. The 




larvae were transferred into tanks in the aquatic system when they were 
approximately 21 dpf.     
 
1.3 Microinjection into one-cell stage embryos 
 Needles were prepared from glass capillaries using the P-97 Flaming/Brown 
Micropipette puller (Sutter Instrument, USA) using optimised heat and pull time 
conditions. Microinjection was carried out using the FemtoJet microinjector 
(Eppendorf, Germany) using optimised pressure and microinjection time settings. 
Embryos were placed on a glass slide with excess egg water drained off using 
KimWipes tissues (Kimberly-Clark Co., USA) before microinjecting under a 
dissecting microscope. Microinjected embryos were then returned to the petri dishes 
to be reared. 
 To generate the Tg(fabp10:egfp-lc3) transgenic line, 50 ng/µl of the plasmid 
pDS-FABP10-EGFP-LC3 was mixed with 500 ng/µl of Ac mRNA, and the mixture 
was microinjected into one-cell stage embryos. A total volume of 1 nl was injected 
into each embryo. A total of 25 pg of plasmid and 250 pg of Ac mRNA were micro-
injected into each embryo. 
 To generate the Tg(fabp10:mrfp-egfp-lc3) transgenic line, 50 ng/µl of the 
plasmid pDS-FABP10-mRFP-EGFP-LC3 was mixed with 50 ng/µl Ac mRNA, and 
the mixture was micro-injected into one-cell stage embryos. A total volume of 1 nl 
was injected into each embryo. A total of 25 pg of plasmid and 25 pg of Ac mRNA 








1.4 Larval screening and photo-documentation 
 Transgenic larvae were screened based on fluorescence expression, embryos 
were reared until approximately 3 dpf before being screened using a fluorescence 
microscope (Carl Zeiss AG, Germany). Larvae expressing desired fluorescence were 
siphoned with a plastic pipette and reared in a separate petri dish containing egg water.  
 Larvae were photo-documented using the Carl Zeiss Axiovert 200M 
microscope (Carl Zeiss, Germany), using the 2.5X, 5X and 10X objectives after 
anaesthetised using 0.1 %  phenoxy-ethanol (Sigma Aldrich, USA). GFP signals were 
detected using the blue filter while RFP signals were detected using the green filter. 
Images were taken using the attached Axiocam HRC camera mounted on the 
microscope and accompanying software. Images were further processed using Adobe 
Photoshop software (Adobe, USA).  
 
1.5 Liver tissue collection from adult zebrafish 
 Adult transgenic fish were sacrificed to collect their liver tissue for histology 
and protein analyses. Briefly, each fish was first anaesthetised in ice water, after 
which an incision was made from the anus across the belly along the midline, up 
across the pectoral fins and finally along the trunk ending at the anus, with the skin 
removed to expose the liver tissue. Liver tissue was then removed from the trunk 
using a pair of sterile forceps and placed in sterilised microcentrifuge tubes. 
Tumourigenic livers from 3 transgenic fish were pooled together in a single tube, 
while up to 10 non-tumourigenic livers were pooled together in 1 tube. All tubes were 
snapped frozen using liquid nitrogen and subsequently stored at -80 °C.  
 
 




 2. RNA applications 
2.1 Total RNA isolation from embryos and larvae 
 Embryos and larvae at different stages of development were collected in 
sterilised microcentrifuge tubes and snap frozen using liquid nitrogen after draining 
off excess egg water. Total RNA was then extracted using TRIZOL reagent 
(Invitrogen, USA) according to manufacturer’s instructions with some modifications. 
All centrifugation steps were performed at 4 °C. 300 µl of TRIZOL reagent was first 
added to each sample and homogenised using a motorised pestle before adding the 
remaining 700 µl of the reagent. Each sample was then incubated at room temperature 
for 10 minutes to allow nucleoproteins to dissociate; this was followed by the addition 
of 200 µl of chloroform. The mixture was shaken vigorously by hand for 20 seconds 
before incubating at room temperature for an additional 5 minutes. Samples were 
centrifuged at 12,000 g for 15 minutes, after which the aqueous layer was carefully 
transferred to a separate sterilised tube. 500 µl isopropanol was added to each tube to 
precipitate RNA following which the tubes were inverted 10 times by hand and 
incubated at room temperature for 20 minutes. The mixtures were vortexed for 5 
seconds before undergoing centrifugation at 12,000 g for 10 minutes. Excess 
isopropanol was removed and 1 ml of 75 % cold ethanol was added to wash the 
resulting pellet. The pellets were centrifuged again at 7,500 g for 5 minutes before 
draining the ethanol. The pellets were left to air-dry for approximately 5 minutes 
before the addition of diethyl pyrocarbonate (DEPC)-treated water to fully dissolve 








2.2 RNA quantification 
The aqueous RNA was quantified using Nanodrop ND-1000 
spectrophotometer (Thermo Fisher Scientific, USA). The RNA quality was verified 
by running the samples in 1 % agarose gel between 80 to 100 V for approximately 20 
minutes, upon which the gel was photo-documented using the Gel Doc XR Gel 
Documentation System (Bio-Rad, USA). RNA samples were then aliquot into 
separate tubes and stored at -80 °C. 
 
2.3 Ac mRNA preparation 
 The pAc-SP6 plasmid was first linearised using BamHI, and gel purified to 
yield linearised DNA. The linearised DNA was used to generate capped mRNA in 
vitro using the mMessage mMachine SP6 kit (Ambion, USA). Briefly, approximately 
2 µg of linearised template was mixed with 2 µl of 10X Reaction Buffer (containing 
unspecified concentrations of salts, buffer, DTT and other ingredients), 10 µl of 2X 
NTP/CAP (10 mM ATP; 10 mM CTP; 10 mM UTP; 2 mM GTP; 8 mM cap 
analogue), 2 µl of SP6 enzyme mix (buffered 50 % glycerol containing RNA 
polymerase, RNase inhibitor, and other components) and nuclease-free water to give a 
20 µl reaction volume. The mixture was thoroughly mixed and incubated at 30 °C for 
2 hours, following which 1 µl of TURBO DNase (2 units/µl) was added to the 
mixture and incubated at 37 °C for an additional 15 minutes. The resultant capped 
RNA was precipitated by lithium chloride. Briefly, 1 µl 0.5 M EDTA pH 8, 2.5 µl 4 
M lithium chloride and 75 µl 100 % cold ethanol was added to the mixture and left to 
precipitate on ice for approximately 30 minutes, following which the mixture was 
centrifuged at 4 °C at 14,000 rpm for 20 minutes. The supernatant was carefully 
removed and the pellet was washed using 500 µl of 75 % cold ethanol and vortexed. 




The resultant mixture was then centrifuged at 4 °C at 14,000 rpm for 10 minutes. The 
ethanol was decanted, and the pellet was air-dried for approximately 5 minutes before 
being dissolved in DEPC-treated water. The aqueous capped mRNA was then 
quantified using the Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, 
USA), and the quality was verified by running a 1 % agarose gel between 80 to 100 V 
for approximately 20 minutes. The gel was later photo-documented using the Gel Doc 
XR Gel Documentation System (Bio-Rad, USA) to ensure only a single band of size 
between 1 kb and 1.5 kb was seen. mRNA was then aliquot into separate tubes and 
stored at -80 °C. 
 
 3. DNA applications 
3.1 Total DNA isolation  
 Larvae at different stages of development were collected and DNA extraction 
buffer (10 mM Tris-HCl pH8.2; 10 mM EDTA; 200 mM NaCl; 0.5 % SDS), 
proteinase K and RNase were added according to established protocol. Larvae were 
homogenized and incubated at 56 °C for approximately 2 hours, with vortexing every 
30 minutes during incubation. An equal volume of phenol-chloroform was added and 
mixed and centrifuged at 13,000 rpm for 10 minutes. The supernatant was then 
transferred to a separate sterilized microcentrifuge tube and 0.1 volume of 3 M 
sodium acetate (pH 5.2) and 2 volumes of 100 % ethanol were added, mixed and 
incubated at room temperature for 15 minutes, following which the mixture was 
centrifuged at 13,000 rpm for 5 minutes to remove ethanol. The resulting pellet was 
rinsed with 200 µl of 70 % ethanol and centrifuged at 13,000 rpm for 5 minutes, 
following which the excess ethanol was drained off. The pellet was air-dried for 




approximately 5 minutes and TE buffer was added to fully dissolve the pellet. The 
aqueous DNA samples were aliquot into separate tubes and stored at -20 °C. 
 For genotyping Polymerase Chain Reaction (PCR), individual embryos or 
larvae were placed in sterilised microcentrifuge tubes, and covered with 20 µl of 
extraction buffer consisting of 1X PCR Buffer from the GoTaq Flexi DNA 
Polymerase kit (Promega, USA) and proteinase K (1:500 ratio). The mixture was 
subsequently incubated at 60 °C for at least 2 hours, and vortexed after 1 hour of 
incubation. The mixture was quickly centrifuged to pellet the mixture and heated at 
95 °C for 10 minutes to eliminate proteinase K activity. The mixture was 
subsequently stored at -20 °C. 1 µl of the mixture was used to run 1 reaction of 
genotyping PCR. 
 
3.2 cDNA synthesis 
 cDNA synthesis was carried out using isolated total RNA using the 
SuperScript II Reverse Transcriptase kit (Invitrogen, USA). Briefly, total RNA was 
pre-treated with DNase to remove contaminating DNA. 20 µl of aqueous total RNA 
containing 2 µg of RNA, and 2 µl of 0.5 µg/µl oligo-dT and 10 mM dNTPs were 
mixed in a sterilised microcentrifuge tube and incubated at 65 °C for 5 minutes. 8 µl 
of 5X First Strand Buffer (250 mM Tris-HCl, pH 8.3; 375 mM KCl; 15 mM MgCl2) 
were added together with 4 µl of 0.1 M DTT and 2 µl of RNaseOUT (40 units/µl) into 
the mixture and incubated at 42 °C for 2 minutes, following which 2 µl of SuperScript 
II Reverse Transcriptase was added. The entire reaction mixture was incubated at 
42 °C for 50 minutes, and then at 70 °C for 15 minutes to inactivate reverse 
transcriptase activity. The resultant cDNA was diluted 10 times using autoclaved 




MilliQ water and quantified using the Nanodrop ND-1000 spectrophotometer 
(Thermo Fisher Scientific, USA). 
 
3.3 Construction of plasmid DNA 
3.3.1 Restriction endonuclease digestion of DNA 
 Restriction endonuclease digestion of plasmid DNA was performed to release 
desired fragments from a particular plasmid for sub-cloning purposes, or to linearise a 
plasmid in order to insert a DNA fragment into the said plasmid. All restriction 
enzymes used were purchased from New England Biolabs, and digestion reactions 
were performed at 37 °C for 2 hours or according to manufacturer’s recommendations. 
Typically 10 µg of plasmid were used in restriction digestion reactions. All digestion 
reactions were performed in a total volume of either 60 µl or 100 µl, with the volume 
of restriction enzymes not exceeding 10 % of total reaction volume to prevent star 
activity. To stop the reaction, the mixture was immediately placed on ice, following 
which they were mixed with 6X Loading Dye (Fermentas, USA) and run on a 1 % 
agarose gel to separate the fragments. DNA electrophoresis was run at a constant 
voltage of between 80 to 100 V for 20 to 45 minutes, depending on the estimated size 
of fragment and linearised plasmid. Table 1 shows the restriction enzymes used for 











Table 1. Restriction enzymes used for sub-cloning 
Plasmid used Released fragment Restriction enzymes used 
pLF-3.0 EGFP EGFP  MluI, NheI  
pEGFP-LC3 EGFP-LC3 MluI, NheI 
pmRFP-EGFP-LC3 mRFP-EGFP-LC3 MluI, NheI 
pMDS6 Nil, linearise the plasmid 
for sub-cloning 
MluI, NotI 








































   




3.3.2 Recovery of DNA fragments from agarose gel 
 Gel purification is one of the most effective methods to recover and purify 
DNA fragments that were released or digested by restriction enzymes. Gel 
purification reactions in this study were performed using the QIAquick Gel Extraction 
Kit (Qiagen, USA) according to manufacturer’s instructions. Briefly, gel slices 
containing the DNA band of interest were cut from the agarose gel, weighed, and 3 
volumes of Buffer QG (containing guanidinium thiocyanate) were added to 1 volume 
of gel. The resultant mixture was incubated at 50 °C for 10 minutes with occasional 
vortexing to completely melt the gel. This was following by the addition of 10 µl of 3 
M sodium acetate, pH 5.0. For fragments larger than 4 kb, 1 gel volume of 100 % 
isopropanol was added to the mixture. The entire mixture was then loaded into the 
QIAquick column and centrifuged at 14,000 rpm for 1 minute. To completely remove 
traces of agarose gel, an additional 500 µl of Buffer QG was added and centrifuged 
using the same conditions. The column was washed using 750 µl of Buffer PE and 
centrifuged. The column was centrifuged for an additional minute after decanting to 
remove residual Buffer PE. 30 µl of autoclaved MilliQ water was added to the column 
and the column was left to incubate at room temperature for approximately 2 minutes 
before centrifuging at 14,000 rpm for 1 minute to elute the DNA in the column. The 
DNA was quantified and stored at -20 °C. 
 
3.3.3 Ligation 
 Ligation reactions between DNA fragments and vector DNA were typically 
carried out in a 10 µl volume reaction consisting of 1 µl of 10X ligation buffer (0.3 M 
Tris-HCl, pH 7.8; 0.1 M MgCl2; 0.1 M DDT and 5 mM ATP) (NEB, USA), 1 µl T4 
DNA ligase (NEB, USA) and variable volumes of vector DNA, insert DNA and 




autoclaved MilliQ water. Vector DNA and insert DNA were added according to a 
molar ratio of approximately 1:3 or 1:4. The ligation reaction was mixed well and left 
to incubate at 4 °C overnight. Occasionally, 1:10 molar ratios were attempted if 
reactions using molar ratios of 1:3 or 1:4 did not yield successful ligation. 
 
3.3.4 Competent cell preparation 
 Competent bacterial cells are usually used for transformation and re-
transformation reactions. To prepare competent cells, One Shot MAX Efficiency 
DH5α-T1 competent cells (Invitrogen, USA) or any other types of bacterial cells were 
first streaked onto blank Luria Bertani (LB) (Invitrogen, USA) agar plates and 
incubated at 37 °C overnight. One colony was picked from the plate and inoculated 
into 25 ml of LB media and incubated at 37 °C with constant agitation at 250 rpm. 2.5 
ml of the culture was re-innoculated into another 25 ml of LB media and incubated at 
37 °C overnight with constant agitation. The next morning, 0.5 ml of the overnight 
culture was inoculated into 50 ml of LB media and incubated at 37 °C with constant 
agitation for 2 to 3 hours, until the OD600 reached between 0.5 and 0.6. The culture 
was then chilled on ice for 15 minutes after transferring the culture into 50 ml Falcon 
tubes. The competent cells were pelleted by centrifuging at 2,500 rpm at 4 °C for 15 
minutes, following which the supernatant was decanted and the tubes were inverted 
and air-dried to completely remove the supernatant. Cells were suspended in 17 ml of 
CCMB solution (80 mM CaCl2.2H2O; 20 mM MnCl2.4H2O; 10 mM MgCl2.6H20, 10 
mM CH3COOK, 100 ml glycerol), following which the solution was chilled on ice for 
20 minutes. The solution was further centrifuged at 3,000 rpm at 4 °C for 15 minutes, 
following which the supernatant was decanted. The cells were subsequently re-
suspended in 4 ml of CCMB, and incubated on ice for 30 minutes, after which they 




were aliquot into sterilised pre-chilled microcentrifuge tubes in aliquots of 100 µl. 
The tubes were snap frozen using liquid nitrogen and stored at -80 °C.      
 
3.3.5 Transformation and re-transformation reactions 
 Transformation and re-transformation reactions can be prepared using the 
freshly made competent cells. For a transformation reaction, a tube of competent cells 
was first thawed on ice before adding 5 µl of ligation product. The mixture was then 
incubated on ice for 20 minutes before being subjected to 2 minutes of heat shock at 
37 °C. The mixture was then incubated on ice for an additional 5 minutes, after which 
1 ml of LB broth was added to the mixture. The entire mixture was then incubated at 
37 °C for 1 hour with constant agitation at 250 rpm. The mixture was centrifuged at 
4,000 rpm for 4 minutes following incubation, and excess LB solution was decanted, 
leaving approximately 100 µl of LB solution in the tube. The competent cells were 
suspended using the 100 µl of LB solution, following which the competent cell 
mixture was spread on a LB agar plate containing appropriate antibiotics (30 µg/ml 
Kanamycin or 100 µg/ml Ampicillin) using glass beads. The LB agar plate was 
incubated at 37 °C overnight.  
 Re-transformation reactions were performed in order to amplify a given 
plasmid for other experiments. For a re-transformation reaction, a tube of competent 
cells was first thawed on ice before adding 0.1 µl of plasmid DNA. The mixture was 
then incubated on ice for 5 minutes, subjected to 2 minutes of heat shock at 37 °C, 
and then further incubated on ice for an additional 5 minutes. Subsequently, the 
mixture was spread on a LB agar plate containing appropriate antibiotics (30 µg/ml 
Kanamycin or 100 µg/ml Ampicillin) using glass beads. The LB agar plate was 
incubated at 37 °C overnight.  




3.3.6 Colony screening 
 To verify successful ligation and transformation reactions, colony screening 
PCR was performed. Colonies were first marked in numerical order and picked using 
white sterile pipette tips and inoculated into PCR tubes containing 10 µl of antibiotic-
containing LB broth. The PCR tubes were further incubated at 37 °C for 30 minutes 
prior to colony screening PCR using various primers, of which one primer was 
designed to anneal to the vector DNA while its complementary primer was designed 
to anneal to the insert DNA. Such a design allows us to determine the presence of 
insert as well as the orientation of insertion from a single PCR reaction. PCR 
reactions were performed according to section 3.4.1.   
 
3.3.7 Bacterial cell culture and plasmid amplification 
 After selecting for colonies containing the desired inserts in the correct 
orientations, 1 µl of the culture from the PCR tubes were inoculated into tubes not 
containing more than 5 ml of antibiotic-containing LB broth. The cultures were 
incubated at 37 °C overnight with constant agitation at 250 rpm.  
 
3.3.8 Plasmid isolation and purification   
 Following an overnight incubation, the plasmid was isolated and purified 
using the Wizard Plus SV Miniprep DNA Purification System (Promega, USA). 
Overnight culture was centrifuged at 4,000 rpm at 4 °C for 5 minutes, and the 
supernatant decanted. The pellet was re-suspended in 250 µl of Cell Re-suspension 
solution (100 mg/ml RNase A; 10 mM EDTA; 25 mM Tris-HCl, pH 7.5), following 
which 250 µl of Cell Lysis solution (0.02 M NaOH; 1 % SDS) was added to the 
bacterial suspension. The tubes were inverted 6 times by hand to mix the bacterial 




suspension and incubated at room temperature for 2 minutes. 10 µl of Alkaline 
Protease solution was subsequently added and the suspension was mixed by inverting 
the tube 5 times by hand, following which the tube was further incubated at room 
temperature for 5 minutes. 350 µl of Neutralisation solution (4.09 M guanidine 
hydrochloride; 0.759 M CH3COOK; 2.12 M glacial CH3COOH, pH 4.2) was then 
added and the tubes were inverted 5 times by hand. The mixture was centrifuged at 
14,000 rpm for 10 minutes to pellet the bacterial cell debris, and the supernatant was 
transferred to a fresh spin column provided by the kit. The spin column containing the 
supernatant was further centrifuged at 14,000 rpm for 1 minute, following which the 
flow-through was discarded and 750 µl of Column Wash Buffer (162.8 mM 
CH3COOK; 22.6 mM Tris-HCl; 0.109 mM EDTA, pH 8.0; 75 % ethanol) was added 
to wash the plasmid and the spin column was further centrifuged at 14,000 rpm for 1 
minute. After discarding the flow-through, an additional 250 µl of Column Wash 
Buffer was added and the spin column was centrifuged for a second wash step. The 
spin column was then transferred to a new sterile microcentrifuge tube to elute the 
plasmid DNA. 50 µl of autoclaved MilliQ water was added to the spin column and the 
spin column was incubated at room temperature for 5 minutes before being 
centrifuged at 14,000 rpm for 1 minute to elute the plasmid DNA. The plasmid DNA 
was then quantified and 1 µl of plasmid DNA was subjected to gel electrophoresis 
using a 1 % agarose gel to verify and compare migration speed with its predecessors.    
 
3.4 Polymerase chain reaction 
 Polymerase chain reactions are useful to verify as well as amplify DNA 
fragments in a single reaction. PCR reactions have many applications and variations 




in a molecular biology laboratory and we highlight some of the variations that were 
utilised in this study in this section. 
 
3.4.1 Standard PCR 
 Standard PCR reactions were performed using GoTaq Flexi DNA Polymerase 
kit (Promega, USA) with a total reaction volume of 10 µl consisting of 2 µl of 5X 
Green GoTaq Flexi Buffer, 1.2 µl of 25 mM Magnesium Chloride solution, 1 µl of 
dNTP mixture (2 mM ATP; 2 mM GTP; 2 mM CTP; 2 mM TTP), 0.5 µl of 10 µM 
sense primer, 0.5 µl of 10 µM anti-sense primer, 0.2 µl of Taq polymerase (5 units/µl) 
and 0.5 µl of template DNA, with the addition of autoclaved MilliQ water adjusted 
accordingly to obtain a total reaction volume of 10 µl. For colony screening and 
genotyping PCR, 1 µl of bacterial culture was usually added. 
 The PCR programme was typically set up with the following cycling 
parameters: an initial denaturation step at 95 °C for 5 minutes, followed by varying 
number of cycles comprising a three-step cycling of denaturation at 94 °C for 30 
seconds, annealing at 60 °C for 30 seconds and extension at 72 °C for 1 minute. The 
entire PCR programme ends typically with a final extension at 72 °C for 10 minutes. 
The annealing temperature as well as the extension times can both be adjusted for 
optimised PCR reactions depending on the primers used as well as the lengths of 
amplicon. Typically, the annealing temperature will be set to 2 °C lower than the 
lower temperature of a pair of primers, while the extension time is estimated based on 
the formula of 1 min/kb of amplicon. Table 2 shows the primers used for genotyping 
and other variants of standard PCR.  
 
 




 Table 2. Primers used in PCR 




























LC3R Reverse 5'AAGAGCAAGGATGTTCGGGC3' 
β-actin B-actin2F Forward 5'GAGAGAGGCTACAGCTTCAC3' 




















3.4.3 2-step reverse transcription polymerase chain reaction (2-step RT-PCR) 
 The 2-step RT-PCR serves to amplify DNA fragments using mRNA templates. 
It usually starts with cDNA synthesis, as described in section 3.2, before the cDNA 
templates are used in a PCR reaction as described in section 3.4.1. Table 3 shows the 





































lc3 LC3F Forward 5'TTGTAAAGACGGACTTCACAGGACG3' 
lc3 LC3R Reverse 5'AAGAGCAAGGATGTTCGGGC3' 
atg5 Atg5F Forward 5'GGTGTTGTTACCAGCTCCAAA3' 
atg5 Atg5R Reverse 5'TGACCATCACTCCCAATAAGG3' 
β-actin B-actin2F Forward 5'GAGAGAGGCTACAGCTTCAC3' 

























3.5 DNA Vectors 
3.5.1 pLF3.0-EGFP 
 This plasmid is a kind gift from Her et al. (Her et al., 2003). The plasmid 
consists of the liver-type fatty acid binding protein (FABP10) promoter attached to 
egfp. This construct allows egfp expression in the liver and the promoter was used to 
control egfp-lc3 expression in the liver.  
 










 This plasmid is a kind gift from Kabeya et al. (Kabeya et al., 2000). The 
plasmid contains a fusion protein between rat lc3 and egfp. The egfp-lc3 fragment was 
used to generate the Tg(fabp10:egfp-1c3) transgenic line. 
 





















 This plasmid is a kind gift from Kimura et al. (Kimura et al., 2007). The 
plasmid contains a fusion protein between rat lc3, egfp and mrfp. The mrfp-egfp-lc3 
fragment was used to generate the Tg(fabp10:mrfp-egfp-1c3) transgenic line. 
 
 















 This plasmid is a kind gift from Emelyanov et al. (Emelyanov et al., 2006). 
This plasmid consists of a multiple cloning site (MCS) flanked by a pair of Ds 
elements to facilitate transposition in the presence of Ac mRNA. The fabp10:egfp-lc3 
expression cassette was sub-cloned into the MCS and the whole construct and Ac 
mRNA were co-injected into one-cell stage embryos to generate Tg(fabp10:egfp-lc3). 
Similarly, the fabp10:mrfp-egfp-lc3 expression cassette was subcloned into the MCS 
and the whole construct and Ac mRNA were co-injected into one-cell stage embryos 
to generate Tg(fabp10:mrfp-egfp-lc3). 
 














 This plasmid was also a kind gift from Emelyanov et al. (Emelyanov et al., 
2006). This plasmid was used to generate Ac mRNA via in vitro transcription as 
described in section 2.3.  
 










4. Protein applications 
4.1 Total protein isolation and extraction 
 To extract protein from larvae, larvae must first be de-chorionated using a pair 
of forceps followed by gentle washing by swirling larvae in a petri dish containing 
egg water to remove chorion membranes. Next, 50 larvae were placed in a sterilised 
microcentrifuge tube and 100 µl of Tissue Protein Extraction Reagent (T-PER) 
(proprietary detergent in 25 mM bicine; 150 mM sodium chloride, pH 7.6) (Thermo 
Scientific, USA) and 1 µl of protease inhibitor (Roche Applied Science, Germany) 
were added. The whole mixture was homogenised completely, following which the 
mixture was centrifuged at 14,000 rpm at 4 °C for 10 minutes. The supernatant was 
then transferred to a new tube and aliquots were used for protein quantification.  
 
4.2 Protein quantification 
 The Protein Assay Dye Reagent Concentrate (Bio-rad, USA) was used to 
quantify proteins using the microassay procedure using a microtiter plate, according 
to manufacturer’s instructions. Briefly, five dilutions of a protein standard, usually 
Bovine Serum Albumin (BSA) were prepared in autoclaved MilliQ water and 160 µl 
of each standard was pipeted into separate microtiter plate wells. For protein samples, 
2 µl of each sample was pipeted into each well containing 158 µl of autoclaved 
MilliQ water, making up a total of 160 µl. This is followed by pipeting 40 µl of Dye 
Concentrate to each well, where they were mixed by gentle pipeting to avoid bubble 
formation. The entire microtiter plate was then incubated at room temperature for 5 
minutes before the absorbance at 595 nm was measured using the xMark Microplate 
Spectrophotometer (Bio-rad, USA). Protein samples were stored at -80 °C.  




Following protein quantification, protein samples were aliquot into separate 
microcentrifuge tubes, and 6X loading dye (300 mM Tris-HCl, pH 6.8; 12 % (w/v) 
SDS; 0.6 % (w/v) bromophenol blue; 60 % (v/v) glycerol; 3 % beta-mecaptoethanol) 
was added to each sample. The samples were then mixed by gentle pipeting before 
being subjected to denaturation at 100 °C for 5 minutes. Denatured samples were 
stored at -20 °C if not used to run SDS-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) immediately after denaturation.   
 
4.3 Protein Detection 
4.3.1 SDS-PAGE gel casting 
 The SDS-PAGE gel must first be cast prior to running SDS-PAGE. A typical 
SDS-PAGE gel consists of a dis-continuous gel made up of a stacking gel used to 
compress protein samples into a thin line across the gel, and a resolving gel used to 
separate proteins according to molecular sizes. Usually 12 % resolving gels are cast 
and used in a typical SDS-PAGE experiment. Occasionally, 15 % resolving gels are 
used to resolve proteins with small molecular sizes while 10 % gels are used to 
resolve proteins with large molecular sizes. Gels were cast according to standard 
protocols from the manufacturers (Bio-rad, USA). Firstly, 1 mm spacer plates and 
short glass plates were wiped clean with autoclaved MilliQ water and KimWipes 
(Kimberly-Clark Co., USA), after which they were used to form a glass cassette 
sandwich using the casting frame. Varying amounts of autoclaved MilliQ water and 
40 % Acrylamide/Bis solution, 37.5:1 mixture (Bio-rad, USA), 2.5 ml 1.5 M Tris-HCl, 
pH 8.8, 0.1 ml 10 % SDS, 0.1 ml 10 % ammonium persulphate (APS) (Bio-rad, USA), 
and 0.004 ml Tetramethylethylenediamine (TEMED) (Thermo Scientific, USA) were 
added in the stated order to obtain 10 ml of resolving gel solution. The gel solution 




was quickly mixed well by inverting the tube 10 times, following which the solution 
was pipeted into the glass cassette sandwich until a gap of approximately 1.5 cm 
between the top of the gel solution and top of the short plate was left. A layer of 
autoclaved MilliQ water was used to overlay the gel. The resolving gel mixture was 
then left to polymerise for 30 to 45 minutes.  
 To prepare a 4 ml stacking gel, 2.9 ml of autoclaved MilliQ water was 
combined with 0.5 ml 40 % Acrylamide/Bis solution, 37.5:1 mixture (Bio-rad, USA), 
0.5 ml 1.0 M Tris-HCl pH 6.8, 0.04 ml 10 % SDS, 0.04 ml 10 % APS, and 0.004 ml 
TEMED in the stated order and mixed. Next, the gel mixture was poured over the 
hardened resolving gel to the top of the short plate and the comb was placed between 
the glass cassette sandwich and left to polymerise for 20 minutes.  
 
4.3.2 Running SDS-PAGE 
 After both the resolving gel and stacking gel were polymerised, the entire gel 
sandwich was placed in the clamping frame. Usually 2 gels were cast and run at the 
same time; however, a buffer dam will be used when running only 1 gel. Once the 2 
gel sandwiches were placed in perfect alignment in the clamping frame with the short 
plates facing inwards, the arms of the clamping frame will be slid into place to secure 
both gels. The entire set up was then placed in the  Mini-Protean Tetra tank (Bio-rad, 
USA) and the entire tank was filled with 1X running buffer (19 mM Tris; 144 mM 
glycine; 0.075 % SDS; pH 8.3), after which samples were loaded with a pipette. 
Samples were allowed to settle at the bottom of their respective wells before placing 
the lid on the tank and connecting the lid’s electrical leads into the power supply (Bio-
rad, USA). A constant voltage of 100 V was applied for approximately 1.5 hours, 
depending on the size of the proteins of interest and resolving gel percentage.  




4.3.3 Protein transfer from PAGE gel to Polyvinylidene fluoride (PVDF) 
membrane 
 Following SDS-PAGE, the gels were removed from the tank and their gel 
cassettes and the gels were prepared for transfer to a PVDF membrane. Briefly, the 
fibre pads and filter papers pre-soaked in 1X transfer buffer (25 mM Tris; 192 mM 
glycine; 0.01 % SDS; 20 % (v/v) methanol) were used to make a sandwich. The 
cassette was first placed with the grey side down in a tray filled with 1X transfer 
buffer and the sandwich was assembled in the following order: fibre pad, filter paper, 
SDS-PAGE gel, PVDF membrane, filter paper and fibre pad. The PVDF membrane 
was activated prior to adding to the sandwich by soaking in 100 % methanol for 5 
seconds. A 15 ml Falcon tube was used to roll out air bubbles during each step in the 
sandwich assembly. The sandwich was then clamped in place by the cassette and 
placed in the trans-blot tank and filled to the brim with 1X transfer buffer. The entire 
tank was then run at a constant voltage of 100 V for 60 minutes to 90 minutes at 4 °C.    
 
4.3.4 Immunoblotting   
All antibodies were purchased from Sigma Aldrich (secondary antibodies, 
anti-β-actin), MBL International (anti-LC3), Abnova (p62) and Covance (GFP). After 
transfer, the PVDF membrane was removed from the sandwich and placed in 10 ml of 
5 % BSA / 1X TBST (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 0.1 % Tween 20) 
solution per 2 PVDF membranes for blocking at room temperature for 2 hours, 
following which the membrane was cut into various strips for incubation in primary 
antibody-containing BSA solution at 4 °C overnight with gentle agitation. Primary 
antibodies were usually diluted in 1: 1000 ratio in 5 % BSA/TBST solution, with the 
exception of β-actin, which was diluted in a 1:2000 ratio. The following day, the 




primary antibodies were drained out of the container and the membrane strips were 
washed with 15 ml of 1X TBST solution 3 times for 10 minutes each, following 
which horse radish peroxidise (HRP)-conjugated secondary antibodies were added in 
a 1:2000 dilution and incubated at room temperature for 2 hours. After the 2-hour 
incubation, the membranes were washed with 15 ml of 1X TBST solution 3 times for 
10 minutes each.  
 
4.3.5 Protein band detection 
Subsequently, the membranes were then incubated in a 2 ml Working solution 
containing equal parts of the Stable Peroxide Solution and Luminol/Enhancer 
Solution from the SuperSignal West Pico Chemiluminescent Substrate (Pierce, USA) 
for 1 minute. After removing the membranes from the Working solution excess 
solution was removed by tapping the edge of the membrane on an absorbent tissue 
before placing it in a film cassette, with the protein side facing up. A transparency 
slide cut into the shape of the cassette was then placed on top of the membrane and 
after ensuring that the transparency slide is clean a piece of X-ray film (Pierce, USA) 
was gently placed on top of the membrane and the film was exposed for 60 seconds. 
The film was then developed using appropriate developing solution and fixer using 
the film developer machine (Kodak, USA). Various exposure times were attempted to 
ensure sufficient exposure. A maximum of 10 minutes was used to expose a film.    
 
4.3.6 Calculating band intensity from immunoblots 
 The films were scanned and the band intensities were calculated using the 
Image J software (NIH, USA). Briefly, the bands were selected using the Rectangle 
Selection tool and the profile plot of each lane was calculated by using the Plot Lanes 




function. The Straight Line tool was selected and a straight line was drawn across 
each peak to enclose each peak. Each peak was then selected and the Label Peaks 
function was used to label each peak with its size being expressed as a percentage of 
the total size of all the measured peaks. The percentage intensity of each peak was 
then compared to the control peak to obtain each peak’s relative intensity after each 
peak was normalised using respective peaks’ loading control. This data was then 
plotted as a bar chart.   
 
5. Starvation and chemical treatments 
5.1 Starvation treatments 
 Chloroquine was purchased from Sigma Aldrich and dissolved in autoclaved 
MilliQ water to give a stock solution 100 mM. For the set of experiments studying the 
effects of chloroquine in starvation, 50 larvae were placed in a 9 cm petri dish with 25 
ml of egg water. Larvae were not fed from 3 dpf to 8 dpf in order to exhaust the 
nutrient supplies found in the yolk. Larvae were further starved from 8 dpf onwards 
until all larvae in an experimental group died or upon reaching experimental end point, 
whichever is earlier. Egg water was changed every other day during the entire period 
from 3 dpf until the end of the experimental duration. Separate pipettes were used to 
siphon off water in order to prevent cross-contamination from the fed groups as well 
as from groups exposed to chloroquine. Larvae in the fed group were fed chicken egg 
yolk suspension from 8 dpf onwards, where an entire egg yolk was ground and 50 ml 
of autoclaved water was added to give a suspension. Usually 100 µl of egg yolk 
suspension was fed to the larvae in the fed group daily. All larvae were reared at 
28.5 °C in an incubator.  




 For the set of experiments studying intracellular EGFP-LC3 and mRFP-
EGFP-LC3 distribution during starvation, 15 larvae were placed in one well 
containing 15 ml of egg water, using a 6-well plate. Egg water was changed every 
other day and 20 µl of egg yolk suspension was given to the fed control group daily. 
Larvae were starved until 12 dpf before processing for confocal microscopy imaging. 
 
5.2 Chemical treatments 
 Rapamycin and everolimus were purchased from Sigma Aldrich. Each of 
these was dissolved in 100 % DMSO to obtain stock solutions of 10 mM before being 
used in actual chemical exposures. All stock solutions were kept in the dark by 
wrapping the tubes with aluminium foil and stored at -20 °C. 2 dpf wild type larvae 
and 3 dpf transgenic larvae were used in these experiments. 3 dpf transgenic larvae 
were used so as to visualise intracellular GFP-LC3 distribution. Briefly, 15 larvae 
were placed in each well in a 6-well plate and 10 ml of egg water was added to each 
well. DMSO was used as a vehicle control and 100 % DMSO was added to yield a 
final concentration of 0.01 %, while rapamycin, everolimus and chloroquine stock 
solutions were added to yield a final concentration of 1 µM rapamycin or 1 µM 
everolimus and 50 µM chloroquine. The 6-well plates were further wrapped using 
aluminium foil to prevent light exposure and were incubated in a separate incubator at 
28.5 °C for 48 hours. Fresh egg water and fresh chemicals were added after 24 hours 
incubation. Larvae were rinsed with clean egg water twice before being fixed for 
confocal microscopy imaging or being processed for immunoblotting. All liquid 
wastes were pooled, stored and disposed of according to established chemical waste 
disposal protocols in NUS.    
 




5.3 Doxycycline induction of Xmrk and cmyc transgene expression 
 Doxycycline was purchased from Sigma Aldrich and the stock solution was 
prepared by weighing and dissolving doxycycline powder in 40 ml of autoclaved 
distilled water in 50 ml Falcon tubes. The tubes were wrapped in aluminium foil to 
prevent light exposure and stored at -20 °C until use.  
 4 mpf adult transgenic and non-transgenic fish were screened, sorted and 
placed in tanks containing 5 litres of egg water, with each tank containing 40 fish. All 
tanks were placed in a dark room, and fish were fed twice daily with brine shrimp. 
Doxycycline stock solution was added to tanks containing transgenic fish requiring 
doxycycline-induced oncogene expression to yield a final concentration of 60 µg/ml 
doxycycline. Water in the tanks was changed and fresh doxycycline was added every 
other day until the end of the treatment period.  
 During the 3-week recovery period, water in the tanks was changed every 
other day, but doxycycline was not added into any tank. The tanks were kept in the 
same room and under dark conditions.    
 
6. External photo-documentation of adult treated transgenic fish 
 Adult transgenic and non-transgenic fish were first anaesthetised in ice water 
and placed in a plastic weigh boat marked with a 1 cm scale bar. To show the gross 
internal morphology, the skin covering the belly was removed using a pair of scissors 
and forceps before replacing the fish back in the plastic weigh boat. Photographs were 
taken with a digital single-lens reflex camera, and images were processed using the 
Adobe Photoshop software (Adobe, USA), with the cropped images retaining their 
aspect ratio as the original images.    
 





7.1 Cryostat sections of larvae 
 Larvae were fixed using 4 % paraformaldehyde in PBS (PFA/PBS) at 4 °C 
overnight with gentle shaking in the dark by wrapping the tubes with aluminium foil, 
following which the larvae were washed 3 times using PBST (3.2 mM Na2HPO4; 0.5 
mM KH2PO4; 1.3 mM KCl; 135 mM NaCl; 0.05 % Tween 20, pH 7.4)  for 10 
minutes each. The fixed larvae were then transferred into molten 2 % bactoagar/5 % 
sucrose in a cap detached from a microcentrifuge tube at 50 °C. Needles were used to 
orientate the larvae with their heads facing upwards before the agar solidified. The 
block was further trimmed using a razor after solidifying, and was transferred into 30 % 
sucrose solution to be incubated overnight at 4 °C.  
 The block was subsequently placed on a frozen layer of Tissue Freezing 
Medium (Jung, Germany) covering the flat surface of the tissue holder. It was 
subsequently covered with a layer of Medium before freezing it using liquid nitrogen. 
The entire assembly was then placed inside the Leica CM 1900 cryo-microtome 
(Leica, USA) to equilibrate to -30 °C for 2 hours. 12 µm thick sections were made 
and placed on Superfrost Plus slides (Fisher, USA) before being dried on a hot plate at 
42 °C for about 1 to 2 hours. Light was excluded by making a cover using aluminium 
foil and placing the cover over the slides.  
 Following this, slides were washed twice using PBST for 5 minutes each. 
Slides were either processed for Hoechst staining or sealed immediately using 60 µl 
FluorSave Reagent (Merck, USA) and covered using 22 X 60 mm cover slips. The 
slides were left to dry at 4 °C overnight in slide holders.    
 
 




7.2 Cryostat sections of adult tissues 
 Adult fish were sacrificed and fixed in 4 % PFA/PBS in the morning, and the 
adult liver tissue and surrounding gut was removed from the fish and further fixed in 
4 % PFA/PBS overnight with gentle shaking without exposing to light. The livers 
were washed 3 times using PBST for 5 minutes each, before being placed on a layer 
of Tissue Freezing Medium that covered the flat surface of the tissue holder. A layer 
of Tissue Freezing Medium was layered on top of it and the entire assembly was 
subsequently frozen using liquid nitrogen before being placed in the microtome to 
equilibrate for 2 hours. Downstream procedures were identical to cyro-sectioning of 
larvae.  
 
7.3 Hoechst staining  
 Washed slides were immediately stained using Hoechst staining reagent. Each 
slide was incubated with sufficient amount of Hoechst stain so that sections were in 
contact with the staining solution, and left to incubate at room temperature for 20 
minutes in the dark. Subsequently, the slides were tilted to remove the staining 
solution and washed 4 times using PBST, for 10 minutes each. 60 µl of FluorSave 
Reagent was then added to each slide and each slide was covered using 22 X 60 mm 
cover slips. The slides were left to dry at 4 °C overnight in slide holders.     
 
8. Confocal imaging  
8.1 Live confocal imaging 
 Live larvae were first anaesthetised using 0.1 % phenoxy-ethanol (Sigma 
Aldrich, USA) before being transferred to a glass bottom dish (MatTek Co., USA). 1 
drop of molten 1.5 % low melting agarose gel was placed on top of each larva and the 




larva was subsequently positioned using a pair of needles before the agarose solidified. 
Larvae were positioned such that they were lying with their left sides on the bottom of 
the glass bottom dish. Larvae were subsequently imaged for EGFP-LC3 expression 
using the Zeiss LSM510 Meta scanning laser confocal microscope (Carl Zeiss Inc., 
Germany), using an excitation wavelength of 488 nm and 505-530 band-pass filters 
with the Zeiss EC Plan-Neofluar 40X objectives with 2.5 times digital zoom. 
Similarly, an excitation wavelength of 543 nm and a 590-620 band-pass filter were 
used to image mRFP expression. Images were collected and processed using Zeiss’s 
LSM Image Browser software (Carl Zeiss, Germany).  
 
8.2 Confocal imaging of sections 
 Sections were imaged using the Carl Zeiss LSM510 Meta scanning laser 
confocal microscope. Slides were placed with the cover slip-attached side facing 
downwards towards the objectives. Images were taken in a similar manner as 
described in section 8.1.  
 For Hoechst staining, images were taken using an excitation wavelength of 
405 nm. Scanning for Hoechst staining was performed after scanning for EGFP and 
mRFP signals. Images were all collected and processed using Zeiss’s LSM Image 
Browser software as mentioned.   
 
9. Bioinformatics and sequence analyses 
 The National Centre for Biotechnology Information (NCBI) database was 
searched for Atg proteins sequences from mouse, rat, human, African clawed frog, 
chicken, Caenorhabditis elegans, yeast and zebrafish. The blast2seq programme 
freely available from the NCBI website 







used to align human and zebrafish Atg proteins to produce Table 5.  
 Next, the ClustalW2 multiple sequence alignment programme 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) was used to generate multiple sequence 
alignments of LC3 and Atg5, as well as phylogenetic trees, for sequence analyses.  
 
10. Analysis of liver transcriptomic data by deep sequencing 
 Liver transcriptomic data by deep sequencing was available in the lab and 
normalized data were used for analysis in this study. Only normal male liver 
transcriptomic data were used. Atg genes were searched and the average transcripts 

































1. Conserved autophagy machinery in zebrafish 
1.1 Atg gene expression in zebrafish 
 We first investigated atg gene expression in the zebrafish liver using available 
liver transcriptomic data generated by deep sequencing. We found that the zebrafish 
expresses numerous atg genes in the liver as shown in Table 4. Among them, atg13 
has the highest average transcript per million (TPM) reads of 191.8964, while atg2 
has the lowest average TPM reads of 0.2825. We did not find any transcripts 
corresponding to atg7 and atg12. 
 
1.2 Conservation of Atg proteins in zebrafish 
To examine if the zebrafish genome encodes proteins required for the 
autophagic process, we first performed a search for zebrafish Atg proteins in the 
National Centre for Biotechnology Information (NCBI) database. As seen in Table 5, 
the zebrafish indeed has Atg proteins that are crucial for autophagy, including a few 
proteins such as Atg7 and Atg12 that are predicted from existing genomic information 
available in NCBI. Moreover, the human and zebrafish Atg protein orthologues 
displayed remarkable homology when they were aligned using the blast2seq 




identity scores ranging from 50 % to 93 %.  
 As we are planning to generate a transgenic line expressing liver-specific 
EGFP-LC3 and mRFP-EGFP-LC3, we decided to look at the LC3 protein in more 





norvegicus (rat), Homo sapiens (human), Xenopus laevis (African clawed frog), 
Gallus gallus (chicken), Caenorhabditis elegans, and Saccharomyces cerevisiae 
(yeast) with that of zebrafish showed high conservation of amino acid residues across 
the entire LC3 protein (Figure 9A). Figure 9B also showed the evolutionary 
relationship of LC3 from these organisms, suggesting that zebrafish LC3 is almost as 
conserved as LC3 from mammalian species despite being in a different branch. Atg5 
plays an important role in the regulation of autophagy, thus we are also interested to 
find out if zebrafish Atg5 is similarly conserved. Amino acid alignment of Atg5 
revealed that zebrafish Atg5 is highly similar to mammalian Atg5, as shown by the 
highly conserved amino acid sequence as well as from phylogenetic tree analyses 
(Figure 10). It can be concluded from the above evidences that zebrafish Atg proteins 


















Table 4 atg gene expression in the zebrafish  
atg gene  Refseq sequence Average TPM 
ulk1a NM_001130631 0.43 
atg2b XM_001340472 0.28 
atg3 NM_200022 13.83 
atg4b NM_001089352 16.23 
atg4c NM_001002103 0.77 
atg4d XM_001333057 0.29 
atg5 NM_205618 5.65 
beclin1 (atg6) NM_200872 4.57 
map1lc31a (lc3) NM_214739 87.11 
atg9a NM_001083031 0.50 
atg10 NM_001037124 12.29 
atg13 NM_200433 191.90 






Table 5 Comparison of zebrafish and human Atg proteins. 
Name Refseq sequence (Human) Refseq sequence (Zebrafish) Alignment scores 
      Identities Positives E-value 
Atg1 (unc 51-like-kinase 1, Ulk1) NP_003556 NP_001124103 50 % 62 % 0 
Atg3 NP_071933 NP_956316 82 % 90 % 2.00E-159 
Atg4B NP_037457 NP_001082821 73 % 83 % 3.00E-177 
Atg5  NP_004840 NP_991181 81 % 90 % 1.00E-138 
Atg6 (Beclin1) NP_003757 NP_957166 78 % 87 % 0 
Atg7 NP_006386 XP_002667343 (obsolete) 72 % 80 % 2.00E-138 
Atg8 (LC3B) NP_073729 NP_955898 93 % 96 % 3.00E-59 
Atg9 NP_076990 NP_001076500 70 % 80 % 0 
Atg10 NP_113670 NP_001032201 50 % 50 % 1.00E-61 
Atg12 NP_004698 XP_699602 72 % 78 % 2.00E-48 
Atg13 NP_001136145 NP_956727 74 % 83 % 0 
Atg14 NP_055739 NP_001019983 67 % 85 % 0 
Atg16 NP_110430 NP_001017854 68 % 83 % 5.00E-126 











Figure 9 Conservation of LC3 protein in zebrafish. (A) Amino acid sequences 
from various species were compared using ClustalW2 software, with zebrafish LC3 
showing evolutionarily conserved amino acid sequence. (B) A phylogram generated 
using the same ClustalW2 software, showing inferred evolutionary relationships 
among LC3 from various species. It also showed that zebrafish LC3 is closely related 
























Figure 10 Conservation of Atg5 protein in zebrafish. (A) Amino acid sequences 
from various species were compared using ClustalW2 software, with zebrafish Atg5 
showing evolutionarily conserved amino acid sequence. (B) A phylogram generated 
using the same ClustalW2 software, showing inferred evolutionary relationships 
among LC3 from various species. It also showed that zebrafish Atg5 is closely related 























1.3 Expression of autophagic genes and proteins in zebrafish 
In order to investigate if the autophagic genes are expressed during zebrafish 
embryogenesis, reverse-transcription polymerase chain reaction (RT-PCR) of lc3 and 
atg5 using RNA isolated from wild-type 1-cell stage embryos through 96 hours post 
fertilisation (hpf) larvae was performed to study their temporal expression patterns. 
We detected both lc3 and atg5 transcripts from 1-cell stage embryos onwards, 
suggesting maternal deposition of both transcripts (Figure 11). Activation of zygotic 
expression of genes beyond 4 hpf might help maintain the expression level of both lc3 
and atg5 mRNAs during early embryonic development. Such expression patterns 
suggested that both lc3 and atg5 may play important roles during early embryonic 
development, especially the first four hours after fertilisation, during the cleavage 
stage of embryonic development.   
We then investigated if expression of lc3 corresponded to protein expression 
as well as phosphatidylethanolanime (PE) conjugation of LC3 by immunoblotting for 
LC3 proteins using anti-rat LC3 antibodies. Cytoplasmic LC3, or LC3-I, exists as a 16 
kD species, while the PE-conjugated LC3-II has a size of 14 kD due to the increased 
migratory speed conferred by the PE moiety. Immunoblotting using proteins extracted 
from wild-type whole larvae from 1 dpf to 5 dpf was shown in Figure 12. Results 
revealed that LC3-I was expressed from 1 dpf onwards and that PE conjugation only 
occurred after 1 dpf, as evidenced by the presence of the 14 kD LC3-II band in 2 dpf 
samples. This result further proved that zebrafish LC3 undergoes similar post-
translational modification as its mammalian counterparts. Results further showed 
increases in LC3-II levels from 2 dpf to 4 dpf, suggesting that overall autophagic flux 
may be increased during this developmental period. However, there was a great 





degradation in the lysosome from 5 dpf. We further observed that different batches of 
larvae kept under similar conditions produced varying levels of LC3-I and LC3-II 
throughout the first five days of development, suggesting that autophagy may be 






























Figure 11 Temporal expression patterns of lc3 and atg5. (A) Temporal expression 
of lc3 transcripts revealed maternal deposition of lc3, suggesting the importance of 
LC3 protein expression or autophagy function during early development. (B) 
Temporal expression of atg5 transcripts revealed that, similar to lc3, maternal 
deposition of atg5 occurred, highly suggesting an unknown role of Atg5 protein 
function or autophagy function during early embryonic development. β-actin served 








Figure 12 LC3-I and LC3-II protein levels from 1 dpf to 5 dpf zebrafish larvae. 
LC3-I conversion to LC3-II occurred from 2 dpf, as faint LC3-II levels can be 
observed from the immunoblot. LC3-II levels increased from 2 dpf to 4 dpf, 
suggesting induction of autophagy during this developmental period. Greatly reduced 
LC3-I and LC3-II levels were observed at 5 dpf, suggesting increased degradation. 





















1.4 Conserved autophagic machinery in zebrafish 
Having establishing that the zebrafish possesses atg genes and expresses Atg 
proteins and that zebrafish LC3 undergoes similar post-translational modification like 
its mammalian counterparts, we then assessed the functional conservation of the 
zebrafish autophagic machinery and its amenability to chemical manipulation. In 
mammalian and yeast cells, autophagy induction or increased autophagic flux is 
manifested as an increase in LC3-II levels although a blockage at the final stage of 
autophagy - lysosomal degradation - can also bring about an increase in LC3-II levels. 
An increase in LC3-I with concomitant reduction in LC3-II levels are often seen when 
autophagy inhibition is effected at the induction stage. As such, autophagy inducers 
and inhibitors can be used to evaluate the functionality of the autophagic machinery in 
the zebrafish by manipulating autophagy chemically. Rapamycin exerts its effect by 
inhibiting the mTORC1 complex, relieving its inhibitory effect on the ULK1-FIP200-
Atg17 complex necessary for autophagy induction, thereby enhancing autophagosome 
formation and LC3-II levels. However, this increase in LC3-II levels may not be 
significant due to continuous lysosomal degradation of LC3-II in the autolysosome. 
Thus the lysosomotropic alkaline chloroquine is also used simultaneously to discern 
the changes in LC3-II levels as it effectively interferes with the final stage of 
lysosomal degradation of sequestered materials. As chloroquine interferes with the 
degradation of sequestered materials in the autolysosomes, it can also be used as an 
autophagy inhibitor. 
 To assess autophagy induction, we exposed wild-type 2 dpf larvae to 1 µM 
rapamycin for 8 hours. Another group of larvae were pre-treated with 50 µM 
chloroquine for 1 hour before being exposed to rapamycin for 7 hours. In addition, 





as vehicle controls. At the end of the treatment, samples with 1 hour pre-treatment 
with chloroquine followed by 7 hours of rapamycin exposure saw a more significant 
increase in LC3-II levels than the samples that were exposed to rapamycin only 
(Figure 13). This thus proves that the zebrafish autophagic machinery is conserved 
and is also amendable to chemical treatment like its mammalian counterparts.   
 Autophagy is up-regulated by cells in response to cellular stress such as 
starvation in order to survive the stress period. Accordingly, cells fail to survive the 
stressor if they fail to induce autophagy as a means of cell survival. To evaluate this 
survival function of autophagy, 8 dpf larvae were continuously exposed to 50 µM 
chloroquine under both fed and starved conditions as shown in the schematic in 
Figure 14, and their survival rates were noted. Continuous exposure to chloroquine 
led to early deaths regardless whether the larvae were fed or starved, while larvae not 
exposed to chloroquine survived better, with starved larvae surviving slightly better 
than those that were fed. This may be correlated to the amount of debris present in the 
water that feeding may have caused, with the fed larvae exposed to feed that may 
have decayed in the duration of the treatment, leading to an accumulation of toxic 
waste products and/or excess carbon dioxide in the water that caused the death of the 
fed larvae. The early deaths of the larvae exposed to chloroquine may be due to an 
inhibition of protein turnover that is essential for the larvae to survive starvation.  
 The above results led us to conclude that the autophagic machinery is highly 
conserved and obviously functional in the zebrafish, and that it functions very 
similarly to the mammalian and yeast autophagic machinery in ensuring cell survival 
in the face of cellular and environmental stressors. These observations provide 
biological basis for us to generate transgenic zebrafish expressing EGFP-LC3 and 










Figure 13 Autophagy induction by rapamycin. (A) Larvae treated with rapamycin 
showed an increase in LC3-II levels, indicating increased autophagic flux, while 
larvae treated with both rapamycin and chloroquine showed a significant increase in 
LC3-II. Results were representative of at least three independent experiments. β-actin 
served as loading control. (B) Quantification of LC3-II levels relative to β-actin 
loading control from three independent experiments. DMSO: Dimethyl sulfoxide, Rap: 






























Figure 14 Autophagy induction is necessary for larvae to survive starvation. 
(A) Schematic showing the experimental set-up used to investigate the relevance of 
autophagy during starvation. (B) Survival rates of larvae exposed to 50 µM 
chloroquine were greatly reduced regardless of whether they were fed or starved. Fed 
and starved larvae in the absence of chloroquine survived better, although some 
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2. Establishment and characterisation of Tg(fabp10:egfp-lc3) transgenic line 
2.1 Establishing Tg(fabp10:egfp-lc3) transgenic line 
As mentioned previously in the Introduction, autophagy is first studied in the 
livers of animal models, and that the study of autophagy has not been extended to 
zebrafish until recently by He et al. (He et al., 2009), therefore it would be of interest 
to us to study autophagy in zebrafish livers. Furthermore, our lab has generated 
zebrafish models of liver cancer by transgenic expression of oncogenes, thus it would 
be interesting to study the role of autophagy in liver cancer. To analyse the role of 
autophagy in hepato-carcinogenesis we set out to generate a zebrafish transgenic line 
with constitutive liver-specific egfp-lc3 expression.  
 To generate the zebrafish transgenic line the egfp-lc3 expression cassette 
created by Kabeya et al. (Kabeya et al., 2000) was placed downstream under the 
control of a zebrafish liver-specific fabp10 promoter isolated by Her et al. (Her et al., 
2003). We incorporated the Ac/Ds transposon system to facilitate transgenesis, 
generating the plasmid construct pDS-FABP10-EGFP-LC3 as shown in Figure 15. 
We further compared LC3 protein sequences from rat and zebrafish to ensure high 
homology between the two as the expression cassette utilises lc3 isolated from rat. 
Sequence alignment in Figure 16 revealed high sequence identity (93 %) between the 
two, especially at Gly120 where pre-LC3 protein is cleaved by Atg4B forming LC3-I, 
before PE conjugation can take place. This thus ensures that exogenous EGFP-LC3 
will also be recognised by zebrafish Atg4B and be processed in a similar manner as 







Figure 15 The pDS-FABP10-EGFP-LC3 plasmid used in the generation of 
Tg(fabp10:egfp-lc3) transgenic line. The egfp-lc3 fragment was first subcloned into 
the plasmid construct containing the fabp10 promoter, before subcloning the 
fabp10:egfp-lc3 fragment into the plasmid construct containing Ds elements required 






















Figure 16 Sequence identity exists between rat and zebrafish LC3 proteins. 
ClustalW2 was used to study the amino acid sequence of zebrafish and rat LC3. 






















 Microinjection of the pDS-FABP10-EGFP-LC3 plasmid into one-cell stage 
embryos was performed to evaluate the ability of the plasmid in driving EGFP-LC3 
expression in the liver. Faint EGFP-LC3 expression in the liver was first observed at 3 
dpf after microinjection, with increasingly stronger EGFP-LC3 signals as the larvae 
developed in size. Following this evaluation, the pDS-FABP10-EGFP-LC3 plasmid 
was co-injected with Ac mRNA into one-cell stage embryos. As can be seen in Figure 
17, injected larvae expressed EGFP-LC3 in the liver from 3 dpf and the EGFP-LC3 
expression persisted until at least 6 dpf, allowing EGFP-LC3-expressing larvae to be 
selected and bred to maturity for further screening.   
 Screening for founder fish was performed when the EGFP-LC3-positive 
larvae were bred to maturity at around four months post fertilisation (mpf). Each 
founder adult fish was crossed with its corresponding wild-type partner and their F1 
progeny was collected and screened for EGFP-LC3 expression. In total, five out of 11 
fish screened produced progeny with EGFP-LC3 expression. Out of the five founders, 
only one founder (Line 1) was used for subsequent characterisation as the other four 
showed ectopic EGFP-LC3 expression in the gut (Figure 18). Both EGFP-LC3 
positive and negative larvae in Line 1 were processed for genotyping PCR. PCR 
results showed germline transmission of the fabp10-egfp-lc3 expression cassette in 
larvae with EGFP-LC3 expression in the liver, while their non-transgenic siblings did 
not harbour the expression cassette in their genome (Figure 19). Progeny from Line 1 
also expressed increasingly higher levels of EGFP-LC3 in the liver as evidenced from 
their development from 3 dpf to 8 dpf. Immunoblotting for GFP in the liver protein 
lysates from transgenic adult livers showed the expression of EGFP-LC3 fusion 







Figure 17 Liver-specific EGFP-LC3 expression after microinjection of pDS-
FABP10-EGFP-LC3. (A-C) Wild type (5 dpf) un-injected zebrafish larvae did not 
express EGFP-LC3 in the liver. (D-F) Wild type zebrafish larva (6 dpf) with liver-
















Figure 18 EGFP-LC3 expression in the progeny of the five founders. Five 
different founders were identified producing progeny with EGFP-LC3 expression. 
The founders were named according to the sequence in which they were crossed with 
wild type fish. (A-D) Line 1 founder producing progeny with liver-specific EGFP-
LC3 expression, and was chosen for further characterisation. (E-T) Four other 




























Figure 19 EGFP-LC3 positive larvae in Line 1 harbours germline transmission 
of the fabp10:egfp-lc3 expression cassette. (A) Liver-specific EGFP-LC3 expression 
increased in intensity from 3 dpf to 8 dpf. (B) Genotyping PCR revealed germline 
transmission of the fabp10-egfp-lc3 expression cassette in transgenic progeny with 
EGFP-LC3 expression, while the non-transgenic siblings without EGFP-LC3 
expression did not harbour the expression cassette in their genome. β-actin served as 
loading control. NTC: no template control. (C) Immunoblotting for EGFP-LC3 using 
anti-GFP antibodies revealed the presence of a band for both EGFP-LC3 and free 
EGFP in protein lysates from transgenic adult liver. No such bands were detected in 























2.2 Characterisation of Tg(fabp10:egfp-lc3) transgenic line 
We further characterised the F1 progeny from Line 1 for their ability to 
visualise the autophagic flux in vivo. Firstly, the EGFP-LC3 positive larvae were 
subjected to starvation from 3 dpf onwards until 12 dpf when they have exhausted 
their yolk supply in the yolk sac, while the control group were fed throughout the 
entire period. Live imaging using confocal microscopy was performed to visualise 
changes in the intracellular distribution of EGFP-LC3 in the liver. As expected, 
punctate structures of EGFP-LC3 were observed in the livers of larvae subjected to 
starvation, while the fed larvae showed diffused cytoplasmic distribution of EGFP-
LC3 (Figure 20). This result indicated that there was increased cellular turnover 
during starvation and that the autophagic machinery was conserved in the zebrafish. 
This result further proved that the autophagic flux can be studied in the zebrafish in 
vivo using confocal microscopy.  
We further investigated if the transgenic progeny were amendable to chemical 
manipulation of autophagy using everolimus, an analogue of rapamycin, and 
chloroquine. Larvae were exposed to everolimus, chloroquine and a combination of 
everolimus and chloroquine for 48 hours and imaged using the confocal microscope 
as shown in Figure 21. Control larvae displayed a diffused cytoplasmic distribution of 
EGFP-LC3, while small EGFP-LC3 puncta were observed in larvae exposed to 
everolimus, and to the combination of everolimus and chloroquine, as a result of an 
induction in autophagy. However, there was no observable EGFP-LC3 puncta in 
larvae exposed to chloroquine alone. This is unexpected as chloroquine exposure 
should have increased the number of observable EGFP-LC3 puncta due to disrupted 
lysosomal degradation of EGFP-LC3. However, immunoblotting for LC3 revealed 





similar to published data, as shown in Figure 22. The reason behind this is currently 
unknown.  
We also observed another phenomenon in this set of experiments. The EGFP-
LC3 puncta observed in larvae exposed to chemical inducers and inhibitors were 
smaller than those observed when larvae were subjected to starvation. This may be 
caused by different stimuli and therefore activation of subtly different signalling 
pathways although they may converge on to the mTOR pathway to control autophagy 


























Figure 20 Autophagy induction via starvation. (A) Control larvae that did not 
undergo starvation showed diffused cytoplasmic EGFP-LC3 distribution in 
hepatocytes. (B) Hepatocytes from starved larvae produced EGFP-LC3 puncta under 
starvation conditions, some of the autophagosomes are indicated by the white arrows. 



























Figure 21 EGFP-LC3 puncta formation in the presence of everolimus and 
chloroquine. 3 dpf larvae were exposed to 1 µM of everolimus, 50 µM of 
chloroquine or to a combination of both as indicated in the figure for 48 hours. 100% 
DMSO was dissolved in egg water to a final concentration of 0.01% and acted as 
vehicle control. (A-D) Hepatocytes showed diffused cytoplasmic EGFP-LC3 
distribution in water and in vehicle control. (E-F) Small EGFP-LC3 puncta were 
observed in hepatocytes of larvae exposed to 1 µM everolimus. (G-H) No significant 
EGFP-LC3 puncta were observed in hepatocytes of larvae exposed to 50 µM 
chloroquine. (I-J) Larvae exposed to both 1 µM everolimus and 50 µM chloroquine 
had EGFP-LC3 puncta in their hepatocytes. EGFP-LC3 puncta were indicated with 
white arrows. Cell nuclei were indicated by blue Hoechst staining. EVE: 1 µM 

















































Figure 22 LC3-I and LC3-II after chemical exposure for 48 hours. (A) A small 
increase in LC3-II amounts were observed after larvae were exposed to everolimus, 
while a small increase in LC3-I was observed in larvae exposed to chloroquine. 
Larvae exposed to both had markedly increased LC3-I and LC3-II levels, indicative 
of autophagy induction. β-actin served as loading control. (B) Quantification of LC3-
II levels relative to β-actin loading control from three independent experiments. 























3. Establishment and characterisation of Tg(fabp10:mrfp-egfp-lc3) transgenic line 
3.1 Establishing Tg(fabp10:mrfp-egfp-lc3) transgenic line 
 As described earlier on the use of the mRFP-EGFP-LC3 fusion protein to 
detect and measure autophagic flux, we also attempted to generate a transgenic line 
with constitutively liver-specific mRFP-EGFP-LC3 expression. To generate this 
transgenic line, we sub-cloned the mrfp-egfp-lc3 expression cassette created by 
Kimura et al. (Kimura et al., 2007) downstream of the fabp10 promoter before sub-
cloning the fabp10:mrfp-egfp-lc3 fragment into the pMDS6 plasmid construct to 
generate the pDS-FABP10-mRFP-EGFP-LC3 plasmid construct as shown in Figure 
23.   
 The plasmid was microinjected into one-cell stage embryos to evaluate the 
ability of the plasmid in driving mrfp-egfp-lc3 expression in the liver. As expected, 
both EGFP and mRFP signals were observed in the livers of 3 dpf microinjected 
larvae. The plasmid was also co-injected with Ac mRNA into one-cell stage embryos 
and larvae with both EGFP and mRFP expression as shown in Figure 24 were reared 
to maturity at around 4 mpf before screening for founder fish. Two founder adult fish 
were identified to produce progeny with liver-specific EGFP and mRFP fluorescence. 
Genotyping PCR using genomic DNA isolated from the progeny with EGFP and 
mRFP fluorescence showed germline transmission of the fabp10-mrfp-egfp-lc3 










Figure 23 The pDS-FABP10-mRFP-EGFP-LC3 plasmid used in the generation 
of Tg(fabp10:mrfp-egfp-lc3) transgenic line. The mrfp-egfp-lc3 fragment was first 
subcloned into the plasmid construct containing the fabp10 promoter, before 
subcloning the fabp10:mrfp-egfp-lc3 fragment into the plasmid construct containing 






















Figure 24 Liver-specific mRFP-EGFP-LC3 expression after microinjecting the 
pDS-FABP10-mRFP-EGFP-LC3 plasmid into one-cell stage embryos. (A-C) 
Wild type (5 dpf) zebrafish larvae did not express mRFP-EGFP-LC3 in the liver. (D-F) 
Wild type zebrafish larva (4 dpf) with liver-specific mRFP-EGFP-LC3 expression 






























Figure 25 Transgenic larvae harbours germline transmission of the fabp10:mrfp-
egfp-lc3 expression cassette. Genotyping PCR revealed germline transmission of the 
fabp10:mrfp-egfp-lc3 expression cassette in transgenic progeny with both EGFP and 
mRFP expression, while the non-transgenic siblings without both EGFP and RFP 
expression did not. Identical results were obtained from the two transgenic lines 








































3.2 Characterisation of Tg(fabp10:mrfp-egfp-lc3) transgenic line 
 We next proceeded to characterise the F1 progeny of Line 2 for their ability to 
visualise the autophagic flux. Similar to the Tg(fabp10:egfp-lc3) transgenic line, the 
two-colour transgenic progeny were also subjected to starvation from 3 dpf to 12 dpf, 
while the control larvae were fed throughout the entire period. Live imaging using a 
confocal microscope revealed the formation of obvious red puncta corresponding to 
autolysosomes in starved larvae, although we did not observe any significant 
increases in yellow puncta corresponding to autophagosomes in the starved larvae 
(Figure 26). As this is an initial experiment, more studies need to be performed to 
confirm this observation.  
 We also investigated if we can utilise the transgenic progeny to visualise the 
autophagic flux under chemical treatment using everolimus and chloroquine. 
Similarly, transgenic larvae were treated with everolimus, chloroquine and a 
combination of everolimus and chloroquine for 48 hours and imaged using a confocal 
microscope. Larvae treated with everolimus alone displayed increased numbers of red 
puncta, although we did not observe a corresponding increase in yellow puncta in the 
same larva (Figure 27). Larvae treated with chloroquine alone displayed more yellow 
puncta corresponding to autophagosome formation without any concomitant increase 
in red puncta indicative of blocked maturation of autophagosomes into autolysosomes, 
while larvae treated with a combination of both everolimus and chloroquine had 
increases in both red and yellow puncta, indicative of increased autophagic flux. As 
this is also an initial experiment to test the validity of our transgenic line, more studies 








Figure 26 Starvation induces autophagy. (A) Control larvae that did not undergo 
starvation did not show obvious red and yellow puncta formation in the hepatocytes. 
(B) Hepatocytes of starved larvae produced red puncta corresponding to 
autolysosomes while there was no significant increase in the numbers of yellow 
























Figure 27 Red and yellow puncta formation in the presence of everolimus and 
chloroquine. 3 dpf transgenic larvae were treated with 1 µM everolimus, 50 µM 
chloroquine or a combination of both as indicated in the figure for 48 hours. Control 
larvae were placed in egg water for 48 hours. (A-B) No obvious red and yellow 
puncta were observed in control larvae. (C-D) Red puncta were observed without 
significant yellow puncta formation when larvae were treated with everolimus. (E-F) 
Slightly more yellow puncta were observed in larvae treated with 50 µM chloroquine. 
(G-H) Significantly increased red and yellow puncta were observed in larvae treated 
with both 1 µM everolimus and 50 µM chloroquine. Cell nuclei were indicated by 
blue Hoechst staining. EVE: 1 µM everolimus, CQ: 50 µM chloroquine. Images were 

























4. Establishing the role of autophagy in liver cancer 
With the establishment and characterisation of the Tg(fabp10:egfp-lc3) 
transgenic line, we further investigated if we could extend the use of this transgenic 
line to study the involvement of autophagy in liver cancer using our liver cancer 
transgenic models (Huang et al., 2011; Li et al., 2011; Nguyen et al., 2011). Currently 
we have developed two liver cancer models based on oncogene over-expression in the 
liver. The Tg(fabp10:TA; TRE:Xmrk; krt4:GFP) and the Tg(fabp10:TA; TRE:cmyc, 
krt4:RFP) transgenic lines were generated to study liver cancer, with the former line 
developing hepatocellular carcinoma (HCC) and the latter line developing 
hepatocellular adenoma (HA), as shown in Figure 28 (Huang et al., 2011). Moreover, 
the use of the Tet-on inducible system further allows us to control the temporal 
expression of the oncogene, allowing us to study tumour initiation, progression and 
regression. This would also facilitate our study of the autophagy status and role in 















Figure 28 Over-expression of cmyc and Xmrk led to liver tumour formation in 
stable transgenic zebrafish induced using 60 µg/ml doxycycline. Fish were treated 
with 60 µg/ml doxycycline from 21 dpf onwards for 30 days. (A, D, G) External gross 
morphology and histo-pathological analysis of a non-transgenic fish used as a control. 
(B, E, H) Fish over-expressing cmyc developed an enlarged liver and developing 
hepatocellular adenoma. (C, F, J) Fish over-expressing Xmrk developed a discoloured 
and enlarged liver. Histo-pathological analysis revealed the fish developing 
hepatocellular carcinoma. White dotted lines demarcate liver tissue from surrounding 
tissue in the fish. HA: hepatocellular adenoma, HCC: hepatocellular carcinoma. 














4.1 Preliminary data implicating autophagy inhibition in liver cancer 
Activation of autophagy often entails the suppression of the mTOR pathway 
with a concomitant reduction in the phosphorylation of targets downstream of the 
mTOR complex 1 (mTORC1) such as p70 ribosomal S6 kinase (S6K), and eukaryotic 
initiation factor 4E binding protein 1 (4EBP1) (Corradetti and Guan, 2006). This 
indirectly leads to reduced amounts of phosphorylated S6 ribosomal protein (p-S6), a 
target of phospho-S6K. This relationship between mTORC1 activation and increased 
amounts of p-S6 can be exploited as readout for mTOR activation. Immunoblotting of 
lysates of both 4- and 8-month old Xmrk over-expressing zebrafish liver saw an 
increase in p-S6, reflecting mTOR activation, while the untreated transgenic and non-
transgenic sibling fish did not (Figure 29). An increase in LC3-I levels were also 
observed in fish with elevated levels of p-S6, suggesting that autophagy may be 
blocked due to activation of the mTOR signalling pathway. However, we were unable 
to determine the amounts of LC3-II levels, thus it would be premature for us to 
conclude that autophagy blockage was caused by mTOR activation. This observation 













Figure 29 mTOR activation may cause autophagy inhibition in fish with Xmrk 
over-expression. Both 4 months and 8 months old transgenic fish treated with 
doxycycline (Dox) showed elevated p-S6 levels, indicative of mTOR activation. LC3-
I levels were also elevated in these Dox-induced transgenic fish compared to wild 
type treated or transgenic non-treated controls, suggesting autophagy inhibition. LC3-
II levels remained to be determined. Fish liver lysates were used for immunoblotting. 

















4.2 Establishing double transgenic lines with liver-specific oncogene over-
expression and EGFP-LC3 expression to study the role of autophagy in liver 
cancer 
 In order to study the autophagic flux in the zebrafish liver cancer models in 
vivo, we crossed the Tg(fabp10:TA; TRE:Xmrk; krt4:GFP) and Tg(fabp10:TA; 
TRE:cmyc; krt4:RFP) transgenic lines with Tg(fabp10:egfp-lc3) to produce double 
transgenic fish, with Figure 30 detailing the progeny genotypes that resulted from a 
cross involving Tg(fabp10:TA; TRE:Xmrk; krt4:GFP). Fish exposed to doxycycline 
(treatment group) and their respective controls were grouped as in Figure 30. Progeny 
resulting from crossing Tg(fabp10:TA; TRE:cmyc; krt4:RFP) and Tg(fabp10:egfp-lc3) 
were treated in an identical manner as the above. The double transgenic fish were 
induced to over-express Xmrk and cmyc respectively in order to develop liver cancer 
upon doxycycline exposure when they were approximately 4 mpf. Fish were sampled 
every two weeks to follow tumour initiation and progression, and doxycycline was 
withdrawn after six and a half continuous weeks of doxycycline exposure to effect 
tumour regression. Figure 31 showed the schedule for both doxycycline exposure as 
well as sampling time points for the double transgenic fish. External gross 
morphology, and internal gross morphology were taken note of and photo-
documented, while liver tissue were taken from fish for processing for 











Figure 30 Schematic showing the genotypes of progeny resulting from crossing 
Tg(fabp10:TA; TRE:Xmrk; krt4:GFP) with Tg(fabp10:egfp-lc3), and doxycycline 
exposure and control groups. Fish expressing Xmrk and egfp-lc3 (L+X+) as well as 
egfp-lc3 only (L+X-) were selected and grouped as shown in the schematic. Each 
group were further divided into two sub-groups, one of which was treated with 60 
µg/ml doxycycline (denoted by red dotted circles) while the other group were not, 














Figure 31 Schedule for doxycycline exposure and sampling time points. 
Doxycycline treatment was continuous for six and a half weeks to allow tumour 
formation and development, following which doxycycline was withdrawn and 
tumours were allowed to regress. Sampling took place approximately every two 
weeks, with the exception of the fourth sampling time point, where it took place one 











5th sampling at 9.5 weeks  
Recovery (no doxycycline added from here on) 
4th sampling at 7.5 weeks 
Continue treatment  
3rd sampling at 6.5 weeks  
Continue treatment  
2nd sampling at 4.5 weeks  
Adult double transgenic and control fish doxycycline treatment 





4.2.1 Tg(fabp10:TA; TRE:Xmrk; krt4:GFP) 
Treated double transgenic fish over-expressing Xmrk developed liver tumours 
as expected within six and a half weeks of doxycycline exposure, with the tumours 
regressing following three weeks of doxycycline withdrawal (Figure 32). We 
observed the double transgenic fish developing increasingly larger bellies due to 
enlargement of the liver tissue as time progressed, with noticeable liver tissue 
discolouration. Upon dissection, the liver tissue had a firmer consistency, unlike the 
controls that had liver tissue with a softer consistency. These observations 
corresponded to the severity of the liver tumours developed, with firmer consistency 
positively correlated with severity of the tumours developed. The size of the liver 
tissue returned to near normal when regression was induced with doxycycline 
withdrawal, with the return of near normal liver consistency and colouration when 
compared to the controls. Confocal imaging of double transgenic fish livers over-
expressing Xmrk also revealed altered cell morphology with increasing severity as the 
tumours developed. They also displayed diffused intracellular cytoplasmic EGFP-
LC3 and no obvious EGFP-LC3 puncta were observed. We further observed cell 
morphology returning back to near normal as tumours regressed, with the re-
appearance of EGFP-LC3 puncta three weeks after tumours were induced to regress 
(Figure 32).  
We also examined the protein levels of LC3-I, LC3-II, p62 as well as EGFP-
LC3 and free EGFP in these fish (Figure 33). p62 levels can be used to estimate the 
autophagy status as it interacts with LC3 via a LC3 recognition sequence (LRS) and is 
a substrate for autophagic degradation and accumulation of p62 is correlated with 
defective autophagy (Komatsu and Ichimura, 2010). We found that L+X+D+ fish had 





duration, despite the failure to detect significant EGFP-LC3 in the other controls. We 
hypothesised that this may be due to a blockage in autophagy, causing EGFP-LC3 to 
accumulate in L+X+D+ fish. However, the levels of free EGFP present did not concur 
with our hypothesis as significant amounts of free EGFP could still be detected in 
L+X+D+ fish during tumour induction as well as during regression. We did not detect 
any changes in p62 levels, thus we could not corroborate p62 levels with autophagy 
status. We were also unable to determine LC3-I and LC3-II levels accurately to arrive 
at any conclusion. We could only hypothesise that autophagy may be inhibited during 
liver tumour formation and development, as such, hypothesising that autophagy may 
serve as an anti-cancer mechanism in Xmrk-induced liver tumour formation.  
 
4.3.2 Tg(fabp10:TA; TRE:cmyc; krt4:RFP) 
 As with the Xmrk over-expressing double transgenic fish, the cmyc over-
expressing double transgenic fish developed tumours that were visible due to their 
severely enlarged livers which manifested as severely enlarged bellies (Figure 34). 
However, we observed that the tumours that developed maintained their consistencies 
as well as colouration when compared to the controls. Liver overgrowth was observed 
in every fish that we sampled at the first three time points. Confocal imaging did not 
reveal any differences in distribution of intracellular EGFP-LC3, thus it was difficult 
for us to ascertain if there was any changes in the autophagic flux.  
We also performed protein analyses on the fish livers. As shown in Figure 35, 
double transgenic (L+M+D+) liver protein samples showed increased free EGFP 
levels in samples during tumour regression, suggesting that there was increased 
lysosomal degradation of EGFP-LC3, though the controls also had increased EGFP 





phase. The double transgenic protein samples also showed reduced p62 levels in the 
fourth and fifth time points, highly suggesting increased lysosomal degradation or 
increased autophagic flux. We also detected slight reduction in EGFP-LC3 levels 
during tumour regression in L+M+D+ fish, suggesting that EGFP-LC3 was probably 
degraded. This observation also corroborated with our observation and hypothesis that 
autophagy may be de-repressed during tumour regression. Immunoblotting for LC3-I 
and LC3-II did not provide any substantial evidence in supporting the notion that 
autophagy was inhibited during tumour progression and they remain to be 
investigated. Although the changes in protein levels in L+M+D+ recapitulated those 
in L+M-D- controls, those from the two other control groups (L+M+D- ad L+M-D+) 
were rather different, suggesting that different genotypes as well as addition of 
doxycycline may have some effect on the fish and on the autophagic process, though 


















Figure 32 Tumour progression manifested as increasingly severe gross and 
cellular morphology in transgenic fish over-expressing Xmrk. Fish were grouped 
according to sampling time point. Liver overgrowth was monitored as treatment time 
lapsed, with significant overgrowth by the third time point. Liver discolouration was 
observed as well and corresponded to severity of tumour. Liver cell morphology was 
also increasingly disrupted, correlating with severity of liver overgrowth and period of 
doxycycline treatment. Doxycycline removal resulted in recovery and tumour 
regression, as evidenced by liver size reduction. Cell morphology returned to near 
normal concurrently. No significant EGFP-LC3 puncta were observed during tumour 
initiation and progression. EGFP-LC3 puncta re-appeared in the fifth time point, 
corresponding to recovery. Dotted lines demarcate liver tissue from surrounding 
tissue. Fish were representative of three different individual fish that were sampled 






Figure 33 Immunoblot analyses of Xmrk over-expressing fish showing increased 
free EGFP. Increased free EGFP were observed in double transgenic fish during 
tumour regression, suggesting either increased autophagic flux or increased lysosomal 
degradation. Double transgenic fish also had visibly increased amounts of EGFP-LC3 
compared to controls. There were no significant changes in p62 levels throughout the 
entire experimental duration. Changes in LC3-I and LC3-II as well as EGFP-LC3 
levels remain to be investigated. Fish liver lysates were used for immunoblotting. 
Numbers refer to time point at which samples were collected. L: EGFP-LC3, X: 















Figure 34 Tumour progression in fish over-expressing cmyc, manifesting as liver 
overgrowth and disruption to cell morphology. Fish were grouped according to 
sampling time point. Liver overgrowth was monitored as treatment time lapsed, with 
significant overgrowth by the third time point. Liver cell morphology was disrupted, 
although not to the extent of fish over-expressing Xmrk. Doxycycline removal 
resulted in recovery and tumour regression, as evidenced by liver size reduction and 
return of near normal cell morphology. No significant EGFP-LC3 puncta were 
observed in any of the fish sampled. Dotted lines demarcate liver tissue from 
surrounding tissue. Fish were representative of three different individual fish that 













Figure 35 Immunoblot analyses of cmyc over-expressing fish showing increased 
free EGFP and reduced p62 levels during tumour regression. Increased free EGFP 
and reduced p62 were observed in double transgenic fish during tumour regression, 
suggesting either increased autophagic flux or increased lysosomal degradation. 
Changes in LC3-I and LC3-II as well as EGFP-LC3 levels remain to be investigated. 
Changes in protein levels in L+M+D+ recapitulated those of L+M-D-, however 
L+M+D- and L+M-D+ did not recapitulate this trend, suggesting that doxycycline as 
well as genotype may play subtle roles in autophagy regulation. Fish liver lysates 
were used for immunoblotting. Numbers refer to time point at which samples were 







































Autophagy is an evolutionarily conserved cellular process that involves the 
degradation of a cell’s cytoplasm, long-lived proteins as well as organelles in the 
lysosome; it enables cells to survive periods of stress such as starvation, and in the 
case of cancer cells, metabolic and therapeutic stress (Klionsky, 2007; Mizushima et 
al., 2008). As such, it is central for cells to be able to regulate autophagy for their own 
survival during periods of cellular stress, and for cancer cells to co-opt autophagy for 
its survival and subsequent proliferation and metastasis. Although autophagy was first 
observed in mammalian hepatocytes, studies on autophagy have been carried out 
mainly in yeast, until recently where more focus is directed towards its involvement in 
diseases including cancer in humans (Klionsky, 2007). Autophagy has been found to 
be evolutionary conserved from yeast to humans (Kourtis and Tavernarakis, 2009; 
Rubinsztein et al., 2007), and in this study, we extended our analyses of autophagy to 
the zebrafish, a model organism where essentially no studies on autophagy have been 
done. We first characterised the autophagic machinery in zebrafish and found it to be 
highly conserved in terms of function like its mammalian counterparts. We further 
generated transgenic lines with constitutively liver-specific egfp-lc3 and mrfp-egfp-lc3 
expression in order to study autophagic flux in the liver. In addition, with our newly 
developed zebrafish models of liver cancer, we can, at the same time study the 
involvement of autophagy in liver cancer caused by oncogene over-expression, and 
expand our knowledge on how these oncogenes affect the regulation of autophagy and 
how dysregulation of autophagy impact on tumour development. 
 
1. Conserved autophagy machinery in zebrafish  
 To study autophagy in zebrafish, we first investigated the atg gene expression 





4). We found that the zebrafish indeed expresses numerous atg genes that encode the 
core proteins required for functional autophagy. However, we failed to detect any 
transcripts corresponding to atg7 and atg12, genes that are required for the autophagic 
process. We hypothesise that lack of studies on autophagy in zebrafish may have been 
the cause of this and propose the existence and nucleotide sequences of these two 
genes be verified. We also found that the zebrafish expresses Atg proteins that have 
high degrees of homology to human Atg proteins when their amino acid sequences 
were compared (Table 5). We also found that Atg7 and Atg12 protein sequences were 
derived from predicted genomic sequences, corroborating with our earlier findings 
that zebrafish atg7 and atg12 genes were still currently uncharacterised. Studies can 
be done to verify and characterise these proteins in detail after their nucleotide 
sequences have been verified.  
We further investigated the degree of similarity of LC3 and Atg5 proteins 
across different mammalian and non-mammalian species, and found them to be highly 
conserved in terms of amino acid sequences as well as types of amino acids at each 
position (Figures 9 and 10). Phylogeny analyses further showed the close evolutionary 
relationships between zebrafish and mammalian LC3 and Atg5, suggesting that the 
function of zebrafish Atg proteins may be well-conserved compared to their 
counterparts in other organisms. Thus, the zebrafish can be used as a complementary 
organism to study autophagy as zebrafish develops externally and this feature of the 
zebrafish facilitates such developmental studies involving autophagy. It can also be 
used as a complementary organism to study the relationship between autophagy and 
cancer.  
 We next set out to study the temporal lc3 and atg5 gene expression pattern 





explained by the presence of their respective mRNA transcripts at the one-cell stage 
(Figure 11), suggesting that autophagy may be involved in as early as during the 
cleavage and blastula stages. This observation was also consistent with findings from 
Tsukamoto et al. that autophagy is triggered by fertilisation and up-regulated in early 
mouse embryos (Tsukamoto et al., 2008). More studies need to be performed to 
confirm if the same occurs during zebrafish development. However, He et al. disputed 
this hypothesis by providing evidence that other atg genes such as ulk1a, ulk1b, atg9a 
and atg9b that are also crucial for autophagy are not expressed until later during 
development (He et al., 2009). Hence our findings of maternal deposition of lc3 and 
atg5 may also point to some unknown function or requirement for the presence of 
these transcripts during development and this may be worthy of investigation. 
Morpholino knockdown of lc3 and atg5 may shed light on the need for maternal 
deposition of these two genes as well as their roles in embryonic development. 
Furthermore, the presence of these two proteins in addition to Ulk1 and Atg9 in the 
first 24 hpf should also be confirmed by immunoblotting.  
Armed with this knowledge, we further investigated the temporal expression 
of LC3 protein during development. We are also interested in finding out if zebrafish 
LC3 undergoes conjugation with phosphatidylethanolamine (PE) like its mammalian 
counterparts. We found that LC3-I was expressed in 1 dpf embryos, while PE 
conjugation occurred only from 2 dpf onwards (Figure 12). This provided evidence 
that LC3 undergoes identical post-translational modification like its mammalian 
counterparts, and that LC3-I and LC3-II can be used as readout for autophagic flux 
under appropriate experimental conditions. We also observed an increase in the levels 
of LC3-II from 2 dpf to 4 dpf, highly suggesting autophagy induction and increased 





for larval development from 2 dpf to 4 dpf as zebrafish larvae undergo developmental 
changes such as fin formation, pigment cell differentiation and circulatory system 
formation among others from 2 dpf to 4 dpf (Kimmel et al., 1995). This observation 
corroborated with findings that autophagy plays an important role in mammalian 
development and cellular differentiation (Mizushima and Levine, 2010). We further 
observed that LC3-II levels were greatly reduced at 5 dpf. This may be due to an 
increased rate of lysosomal degradation or a reduction in the autophagic flux at 5 dpf, 
and we hypothesised that this may be due to autophagic flux returning to a basal level 
as larval morphogenesis comes to an end.  Alternatively, this observation can be 
interpreted as a blockage at the degradation step in the autophagic process from 2 dpf 
to 4 dpf, resulting in an increase in LC3-II levels with a corresponding increase in 
lysosomal degradation, leading to reduced LC3-II levels on 5 dpf. More studies are 
proposed to understand the dynamics of autophagy during larval development, 
especially during the transition from 4 dpf to 5 dpf. 
 We next assessed the conservation of autophagy function in the zebrafish 
larvae using chemical inducers and inhibitors of autophagy (Figure 13). Increases in 
LC3-II were observed after subjecting wild type larvae to rapamycin treatment, 
indicative of autophagy induction, while co-incubation with chloroquine further 
increased LC3-II amounts, which is consistent with published observations 
(Mizushima et al., 2010). Chloroquine, a lysosomotropic agent, inhibits lysosomal 
degradation, which includes degradation of materials sequestered and delivered to the 
lysosome via autophagy as well as LC3-II that is found in the inner and outer leaflets 
of the autophagosomes, resulting in increases in LC3-II levels. The use of chloroquine 
alone can effect autophagy inhibition, which is the basis of our future set of 





 We also assessed the pro-survival function of autophagy by continuously 
exposing wild type zebrafish larvae to chloroquine in the presence and absence of 
food (Figure 14). We observed that continuous exposure to chloroquine lead to early 
deaths regardless of whether the larvae were fed or starved, whereas larvae that were 
not exposed to chloroquine had significantly higher survival rates. This observation 
may be explained by chloroquine inhibiting lysosomal degradation, thereby disrupting 
the intracellular turnover of amino acids and other nutrients and building blocks 
required for cell survival. This set of experiments also recapitulated the observation of 
reduced survival time of neonates deficient in atg5 by Kuma et al., where they 
observed starved neonates deficient in atg5 did not survive as long as starved wild 
type neonates (Kuma et al., 2004). They also observed reduced amino acid 
concentrations in the plasma and tissues as well as signs of energy depletion in these 
atg5-deficient neonates, suggesting that autophagy is required for the maintenance of 
energy homeostasis during neonatal starvation.  Furthermore, Tsukamoto et al. 
published the finding that autophagic degradation in the early mouse embryos was 
necessary for preimplantation development in mammals and that deficient autophagy 
may impair protein recycling in these embryos (Tsukamoto et al., 2008). Thus this 
leads us to hypothesise that autophagy is required for cellular turnover during 
embryonic development as well as survival during early neonatal starvation regardless 
of nutritional availability. Furthermore, this published finding can also be correlated 
to the finding that atg5 transcripts were found in 1-cell stage embryos via maternal 
deposition, although we did not have evidence suggesting autophagic activity during 
the cleavage stage. However we cannot refute the possibility of toxic side effects that 
chloroquine exerts that can cause their early demise, thus we propose that similar 





experiments in order to eliminate the possibility of chloroquine poisoning. 
Experiments using other autophagy inhibitors can also be performed although these 
inhibitors must be used with care as they are not specific for autophagy and may have 
other off-target effects. Similarly, morpholino knockdown can be performed to 
determine the requirement of autophagy genes, such as atg5 for zebrafish larval 
development.  
 
2. Establishment and characterisation of Tg(fabp10:egfp-lc3) transgenic line 
 We further went on to generate a transgenic zebrafish line with liver-specific 
egfp-lc3 expression. We made use of the construct which was a kind gift from Kabeya 
et al. in the generation of our transgenic line (Kabeya et al., 2000). As their construct 
utilised rat lc3 gene, we first compared the degree of similarity between zebrafish and 
rat LC3 amino acid sequence to ensure that rat LC3 will be correctly recognised and 
processed by zebrafish Atg4. We then proceeded to sub-clone the egfp-lc3 fragment 
into the plasmid containing the liver-specific fabp10 promoter so that egfp-lc3 
expression is controlled by the fabp10 promoter. Finally, we utilised the Ac/Ds 
transposition system to increase transgenesis rate, generating the plasmid as shown in 
Figure 15. We found that the larvae had transient liver-specific EGFP expression after 
microinjecting the plasmid, suggesting that the plasmid worked and that expression 
was indeed restricted to the liver through the use of the fabp10 promoter. We then co-
injected Ac mRNA and the plasmid and reared the larvae with EGFP-LC3 expression 
(Figure 17). The use of the transposition system greatly enhanced transgenesis rates, 
as five out of 11 potential founders produced larvae with EGFP expression (Figure 
18). We further went on to verify the sites of EGFP-LC3 expression and found that 





expression, while the other four founders expressed EGFP-LC3 in the gut or had non-
specific EGFP-LC3 expression in tissues surrounding the liver. This may be due to 
the enhancer trap effect that is commonly observed when using transposition systems 
such as the Tol2 transposition system (Kawakami et al., 2004; Parinov et al., 2004). 
Thus we selected Line 1 for further characterisation. Genotyping PCR using primers 
that amplify a DNA fragment containing egfp verified germline transmission of the 
fabp10:egfp-lc3 expression cassette, while immunoblotting using anti-GFP antibodies 
confirmed the expression of GFP-LC3 fusion protein in the transgenic line (Figure 19), 
both evidences suggesting the successful integration and expression of the transgene 
in the fish. 
We next subjected the transgenic progeny to starvation and successfully 
visualised EGFP-LC3 puncta formation in starved larvae, while the fed larvae serving 
as control had diffused cytoplasmic EGFP-LC3 distribution (Figure 20). As zebrafish 
larvae are able to survive without external nutrient supply for an extended period of 
time, we deliberately starved them from 3 dpf to 12 dpf in order to exhaust the 
nutrient supply found in the yolk to induce starvation, while the control larvae were 
fed from 3 dpf onwards with egg yolk suspension. We observed fewer puncta induced 
in the livers of zebrafish larvae when compared to cell culture conditions and this may 
be due to obvious differences between in vitro and in vivo model systems. We also 
observed that different larvae induced different degrees of EGFP-LC3 puncta 
formation and attributed this to individual differences. In addition, our observations 
were also consistent with those of Mizushima et al. using their GFP-LC3 transgenic 
mice, where starvation-induced autophagic activity differed among individual mice 






 To further prove that our transgenic line was also amendable to chemical 
manipulation by autophagy inducers and inhibitors, we exposed transgenic larvae to 
everolimus and chloroquine (Figure 21). Everolimus is an analogue of rapamycin with 
similar potency and has been used in treating advanced renal cell carcinoma 
(Garnock-Jones and Keating, 2009; Schuler et al., 1997). Thus, we are interested to 
find out if everolimus can induce autophagy in vivo, and if we can adopt its use in 
future experiments involving the liver cancer models. As expected, we observed 
changes in intracellular EGFP-LC3 distribution when transgenic larvae were exposed 
to everolimus, as well as a combination of everolimus and chloroquine for 48 hours. 
We found that the EGFP-LC3 puncta that were induced in the hepatocytes were not as 
numerous than those induced in in vitro systems, again reflecting the differences 
between in vivo and in vitro systems. We further observed that the EGFP-LC3 puncta 
that were induced by chemical treatment were significantly smaller than those 
observed under starvation conditions. We hypothesised that the involvement of the 
upstream AMPK pathway during starvation resulted in larger feedback to the mTOR 
pathway, resulting in larger GFP-LC3 puncta formation. We further hypothesised that 
as everolimus acts mainly on the mTORC1 complex, a smaller feedback may result 
from such an inhibition, resulting in smaller EGFP-LC3 puncta formation. We also 
hypothesised that this difference in puncta size may be due to the application of 
different stimuli, with physiological stimuli like starvation resulting in larger puncta 
being formed and smaller puncta formation in response to chemical stimuli. 
Surprisingly, we did not observe any significant EGFP-LC3 puncta formation in 
larvae treated with chloroquine. Chloroquine being a lysosomotropic agent inhibits 
lysosomal degradation by increasing lysosomal pH, rendering lysosomal enzymes 





and should result in an increase in EGFP-LC3 puncta observed. However, we did not 
observe this increase and thus we put forth the hypothesis that exposure to 
chloroquine alone may be insufficient to induce significant GFP-LC3 puncta 
formation, although we observe increases in EGFP-LC3 puncta formation in larvae 
treated with the combination of everolimus and chloroquine. 
We turned to immunoblotting for LC3 proteins in an attempt to explain these 
observations (Figure 22). We saw a significant increase in both LC3-I and LC3-II in 
larvae exposed to both everolimus and chloroquine, suggesting that inhibition of the 
lysosomal degradation by choloroquine and autophagy induction by everolimus were 
successful. Although we saw an increase in LC3-II levels in larvae exposed to 
everolimus alone, the slight increase can be explained by lysosomal degradation of 
LC3-II in the autolysosomes. Interestingly, larvae exposed to chloroquine alone had 
slightly increased amounts of LC3-II; however this does not explain why we were 
unable to observe any significant GFP-LC3 puncta in the same group of larvae. More 
studies need to be performed to provide a reasonable explanation for this observation.  
 We also further characterise our transgenic line with atg3 knockdown (Cui J, 
unpublished), and proved that GFP fluorescence were absent in morphants, even 
when exposed to both everolimus and cholorquine, while GFP fluorescence were still 
observable in larvae microinjected with control morpholino. This set of experiments 
further proved the value of our transgenic line in studying autophagy and the 
relationship between different Atg proteins in the zebrafish. Our transgenic line, with 
liver-specific EGFP-LC3 protein expression, finds value in studying the relevance of 







3. Establishment and characterisation of Tg(fabp10:mrfp-egfp-lc3) transgenic line 
 We also generated a transgenic zebrafish line with constitutively liver-specific 
mrfp-egfp-lc3 expression using the pDS-FABP10-mRFP-EGFP-LC3 plasmid 
construct shown in Figure 23. Microinjection of both the plasmid and Ac mRNA also 
yielded larvae with liver-specific mRFP and EGFP expression (Figure 24), and two 
founders producing transgenic progeny with germline transmission of fabp10:mrfp-
egfp-lc3 were isolated (Figure 25). One of the founders (Line 2) was randomly 
selected for characterisation for its ability to measure autophagic flux under both 
starvation and chemical treatment.   
 Starvation represents a cellular stressor that up-regulates autophagy, thus 
increases in both the number of red puncta corresponding to autolysosomes and 
yellow puncta corresponding to autophagosomes should be observed in the livers of 
transgenic larvae under starvation conditions. We observed increased numbers of red 
puncta, but we did not observe equivalent increases in the number of yellow puncta, 
which is contrary to what is expected (Figure 26). We hypothesised that what we 
observed may be due to increased rates of autophagosome-lysosome fusion and 
maturation into autolysosomes and increased rates of lysosomal degradation, leading 
to reduced numbers of autophagosomes observed. On the other hand, autophagy 
levels returning to basal levels after prolonged periods of starvation may also result in 
lesser number of autophagosomes compared to autolysosomes. Mizushima et al. using 
their GFP-LC3 transgenic mice showed that more GFP-LC3 puncta were observed in 
the livers following 24 hours starvation, whereas a lesser number of GFP-LC3 puncta 
were observed in the livers after 48 hours starvation (Mizushima et al., 2004). We 
hypothesised that zebrafish, similar to mice, limits the duration of autophagy up-





limitation may also apply to other autophagy-inducing stimuli as well. To prove this, 
we intend to perform daily observations to find out if this applies to zebrafish larvae 
as well.    
 We also subjected the transgenic larvae to identical chemical treatment 
conditions to find out if they can be used to measure autophagic flux. Identical 
conditions were applied to the transgenic larvae and we observed that transgenic 
larvae treated with everolimus alone displayed increased numbers of red puncta 
corresponding to autolysosomes without any concomitant increases in the number of 
yellow puncta (Figure 27). Again, we hypothesised that autophagy levels may have 
returned to basal levels after prolonged periods of induction, causing fewer 
autophagosomes to be observed, or that there was an increased rate of 
autophagosome-lysosome fusion and maturation, leading to reduced numbers of 
yellow puncta observed. We further observed that larvae treated with chloroquine 
alone displayed more yellow puncta compared to red puncta. This is indicative of 
blocked maturation of autophagosomes into autolysosomes. We also observed 
equivalent increases in the number of red and yellow puncta in transgenic larvae 
treated with a combination of both everolimus and chloroquine, indicative of 
increased autophagic flux. We intend to perform experiments involving shorter 
incubation periods with everolimus alone to find out the cause behind the reduced 
numbers of yellow puncta formation observed.  
 
4. Establishing the role of autophagy in liver cancer  
Our lab successfully generated two transgenic lines with inducible oncogene 
over-expression, culminating in the development of liver tumours. In the 





in the development of hepatocellular carcinoma (HCC), while cmyc over-expression  
in the Tg(fabp10:TA; TRE:cmyc; krt4:RFP) transgenic line resulted in the 
development of hepatocelluar adenoma (HA) (Figure 28). Thus we have on hand two 
different transgenic lines that will result in the development of different types of liver 
tumours and these two models are perfect to study the role of autophagy in these two 
tumours. These two transgenic models further allow us to study the interaction 
between Xmrk and cmyc over-expression and regulation of autophagy. As oncogene 
over-expression in both lines are inducible by the addition of doxycycline, both 
transgenic lines further allow us to study the course of tumour development and how 
autophagy may have been affected at different time points in the course of tumour 
development. Similarly, removal of doxycycline causes tumour regression in our liver 
cancer models, and we can also study the relationship between autophagy and tumour 
regression at the same time.   
Our early study revealed that activation of the TOR pathway may be chronic 
in Xmrk over-expressing fish as a result of Xmrk over-expression. We observed that 
transgenic fish over-expressing Xmrk had elevated levels of phosphorylated S6 (p-S6) 
protein, which serves as read out of TOR pathway activation, hence our conclusion 
that TOR pathway may be activated in transgenic fish over-expressing Xmrk (Figure 
29). Xmrk, an orthologue of the EGF receptor, was found to activate intracellular 
signalling pathways such as the ras/raf/MEK/MAPK pathway, and can activate ERK 
(Li et al., 2011). It has also been reported that EGFR signalling will directly and 
indirectly activate the PI3K/Akt signalling pathway (Citri and Yarden, 2006) and that 
the PI3K/Akt signalling pathway is a central regulator of the TOR complex and 
therefore, coupled to the TOR pathway (Fabregat et al., 2007). Our results here 





PI3K/Akt/TOR pathway, and this may have led to an inhibition on autophagy. We 
also observe elevated levels of LC3-I in the same samples with elevated levels of p-S6; 
however, we were unable to determine LC3-II levels as they seem to be non-existent 
in our immunoblotting experiments, as a result, we were unable to determine if 
autophagy has been inhibited in these same samples. This may be due to rapid 
turnover of LC3-II in vivo. Thus more thorough investigation needs to be carried out 
to validate if TOR signalling indeed has been activated and that autophagy is indeed 
been inhibited in Xmrk over-expressing transgenic fish.   
To determine if autophagy has been inhibited in these transgenic fish when the 
oncogenes were over-expressed, we crossed the newly generated Tg(fabp10:egfp-lc3) 
transgenic line with the two oncogene over-expressing transgenic lines to obtain 
progeny that will express EGFP-LC3 both with and without oncogene expression. We 
further separated them into groups with and without addition of doxycycline to induce 
liver tumour formation, while trying to dissect the autophagic flux via confocal 
microscopy. We observed severe overgrowth of liver tissue manifesting as enlarged 
bellies in fish treated with doxyxycline to induce Xmrk and cmyc over-expression. 
Xmrk over-expressing fish were found to develop increasingly larger liver tissue that 
was gradually discoloured, probably due to enhanced proliferation and increasing 
severity of the tumour developed (Figure 32). Accordingly, we observed increasingly 
disrupted cell morphology when observing under the confocal microscope, again 
corresponding to severity of the tumour. We did not find any EGFP-LC3 puncta 
developing in the hepatocytes during doxycycline induction, instead, we found EGFP-
LC3 to be freely distributed in the cytoplasm, suggesting that autophagy may have 
been inhibited. Upon doxycycline withdrawal, the size of the livers shrank to almost 





EGFP-LC3 puncta re-emerged as recovery proceeded suggesting that autophagy may 
have been re-activated once Xmrk over-expression was repressed. Our lab found that 
apoptosis may have played an important role during tumour regression by eliminating 
HCC cells; we also hypothesised that the newly generated normal hepatocytes may 
have replaced these HCC cells and direct reversion of HCC cells to normal 
hepatocytes may have occurred concurrently during tumour regression (Li et al., 
2011). We hypothesise that autophagy may have also been up-regulated during 
tumour regression by both processes, to either aid apoptosis or aid cellular 
differentiation to normal hepatocytes, although more studies are required to prove this.   
We next examined LC3-I, LC3-II, p62, EGFP-LC3 as well as free EGFP 
levels in the protein lysates (Figure 33). We observed increased amounts of EGFP-
LC3 in L+X+D+ protein lysates compared to controls (L+X+D-, L+X-D+ and L+X-
D-) throughout the entire experimental duration from tumour initiation through 
tumour regression except at the last time point (corresponding to three weeks after 
regression was induced). This observation may suggest that there may be an inhibition 
of autophagy flux, especially at the later stages of autophagy involving lysosomal 
degradation, therefore manifesting as significantly increased amounts of GFP-LC3 as 
observed in immunoblots. This increase in EGFP-LC3 was also evident from confocal 
microscopy imaging, where L+X+D+ livers displayed diffused intracellular GFP-LC3 
distribution. The reduction in EGFP-LC3 levels three weeks after tumour regression 
was induced corroborated with the re-appearance of EGFP-LC3 puncta, suggesting 
the blockage of autophagic flux may have been relieved and that autophagy may have 
been involved in recovering from tumourigenesis and generation of normal 
hepatocytes. However, we did not observe any reduction in free EGFP in L+X+D+ 





degradation of EGFP-LC3, thus we were unable to validate if there was indeed a 
blockage in autophagy caused by Xmrk over-expression. Increases in p62 levels are 
usually associated with blocked autophagic flux since p62 is a substrate for autophagy; 
however, we failed to detect any significant changes in p62 levels across samples and 
across time points to further verify if autophagy was indeed blocked. We also failed to 
detect LC3-II accurately in most of our samples, thus we could only hypothesise that 
autophagy may have been blocked during tumour initiation and progression. More 
work needs to be done in order to verify our hypothesis of autophagy being an anti-
cancer mechanism and that it is inhibited during tumourigenesis. 
We also observed severe liver tissue overgrowth manifesting as enlarged 
bellies in cmyc over-expressing fish, although we did not detect any tissue 
discolouration, suggesting that the tumours that developed were not as malignant as 
those that arise from Xmrk over-expression, although the liver tissue overgrowth was 
due to hyper-proliferation of hepatocytes (Figure 34). This was confirmed by histo-
pathological analyses where liver tumours that arise from cmyc over-expression were 
indeed HA (Figure 28). Confocal imaging did not reveal any differences in the 
intracellular distribution of EGFP-LC3 in the hepatoytes either, thus we were unable 
to determine the autophagy status in these tumours. We also carried out 
immunoblotting for several proteins, including EGFP, to determine autophagic flux in 
these fish (Figure 35). We observed increased p62 levels during tumour induction, 
highly suggestive of autophagy repression. Elevated p62 levels could be a driving 
force for tumourigenesis by enhancing oxidative stress and genomic instability as well 
as activating the non-canonical NF-κB pathway, suggesting that autophagy down-
regulation may be favoured during tumourigenesis in order to elevate p62 levels 





levels of free EGFP in cmyc over-expressing fish during recovery, suggesting 
autophagy inhibition may have been relieved to promote recovery. However, the role 
of autophagy during cellular recovery remains to be investigated; although we 
hypothesise that enhanced autophagy may serve to rid the cell of damaging 
superfluous protein aggregates thereby relieving cells of oxidative stress. It may also 
be involved in activating tumour-suppressing pathways as well as cellular remodelling 
or simply aiding apoptosis in riding tumourigenic hepatocytes. Immunoblotting for 
LC3-I and LC3-II were not very successful as we were unable to detect them 
accurately, thus we were unable to further furnish supporting evidence involving 
changes in LC3-II levels for this phenomenon.   
Furthermore, we found difficulty in detecting LC3-I and LC3-II levels in 
immunoblots, and we attributed this to the dynamic nature of the autophagic flux as a 
whole. We suggest adding chloroquine 24 hours prior to sacrificing the fish in an 
attempt to visualise and quantify LC3-II levels. We also hope to make use of the 
Tg(fabp10:mrfp-egfp-lc3) transgenic line to visualise the autophagic flux and hope 
that both transgenic lines will complement each other. 
 
5. Future work and conclusions 
 In this study we attempted to characterise autophagy in zebrafish and found 
that some autophagy genes like lc3 and atg5 were maternally deposited although no 
detectable autophagic activity was detected at the early stages of embryonic 
development. This presents an opportunity to study the relevance of these two 
autophagy genes during early embryonic development. This also provides an 
opportunity for us to learn if these proteins have other functions apart from being 





chloroquine led to catastrophic consequences regardless of larvae being fed or starved, 
further proving that autophagy plays a very important role in cell survival whether 
nutrients are available, although we have to prove that larval deaths were due to 
defective cellular turnover and not due to chloroquine toxicity.  
 We successfully generated and characterised the transgenic line 
Tg(fabp10:egfp-lc3) with liver-specific EGFP-LC3 fusion protein expression in order 
to visualise autophagic flux in real time as well as to provide supporting evidence for 
our immunoblotting findings. We further made use of this transgenic line to study the 
role of autophagy in liver tumourigenesis by crossing this transgenic line with existing 
transgenic lines with inducible oncogene over-expression. We found evidence that 
autophagy may be inhibited during tumourigenesis, regardless of which oncogene was 
being over-expressed, and that its inhibition may be relieved once oncogene over-
expression ceased. To further prove our hypothesis we need to investigate LC3-I and 
LC3-II levels in more detail, as we were unable to detect with accuracy LC3-I and 
LC3-II levels in our samples. Our next step also entails further validation of p-S6 
levels in an attempt to validate TOR signalling pathway activation, as well as to find 
out which pathways were activated and how these pathways cross-talk with the 
autophagy machinery to invoke autophagy inhibition during tumourigenesis. We also 
intend to manipulate autophagy during liver tumourigenesis using chemical inducers 
and inhibitors. To further prove our hypothesis that autophagy may be inhibited 
during liver carcinogenesis, we intend to induce autophagy by exposing the double 
transgenic fish to everolimus to find out if such an induction will lead to slower 
tumour initiation and progression.   
 We also generated the transgenic line Tg(fabp10:mrfp-egfp-lc3) in order to 





utilising differences in the propensity of EGFP and mRFP to fluoresce in acidic 
conditions in order to visualise the autophagic flux from autophagosome formation to 
maturation into autolysosomes. Although more in-depth characterisation is still 
required to validate the functionality of our model, this model will in the future serve 
the function of verifying our data on autophagy inhibition in our liver cancer models 
as well as on studying autophagy in various liver diseases.  
 We believe that our study provides an impetus for more research to be carried 
out in this area and that our data shed more light on the role of autophagy in liver 
tumourigenesis. Moreover, our study provides initial clues that will help improve 
current therapeutic options by designing combinatorial chemotherapy for liver cancer 
in humans using autophagy inducers or inhibitors at the appropriate stages of 
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